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Summary
The aim of this project was to show the presence of 
enhanced presynaptic receptor-mediated mechanisms 
facilitating vascular adrenergic neurotransmission in 
preparations from genetically hypertensive rats 
(spontaneously hypertensive, SH, rat and New Zealand 
Hypertensive, NZH rat) compared to that in normotensive 
rats, Isoprenaline and angiotensin II (All) potentiated 
the pressor response to peri arterial nerve stimulation 
(PNS) in the isolated perfused mesenteric vasculature and 
in the isolated perfused kidney. This potentiation was 
found to be enhanced in preparations from the hypertensive 
rats compared to that in preparations from normotensive 
rats (Wistar and New Zealand Normotensive, NZN, rats). 
ICI 118,551, but not atenolol, effectively inhibited the 
isoprenaline induced facilitation of vascular adrenergic 
neurotransmission without having any effect on the All 
induced potentiation of the pressor responses to PNS and 
noradrenaline (NA) infusion.
That the facilitatory mechanisms are located 
presynaptically was inferred from the comparison of the 
effects of isoprenaline on the pressor response to PNS and 
exogenous NA. Both, [Sar^-Ile^] angiotensin II and 
captopril effectively inhibited the isoprenaline induced 
facilitation of vascular adrenergic neurotransmission, 
thereby showing that isoprenaline probably activated the 
vascular renin-angiotensin system to generate All. The
iii
locally generated All then facilitates vascular adrenergic 
neurotransmission and this effect was found to be enhanced 
in preparations from hypertensive rats compared to that in 
the normotensive rats. The next series of experiments 
were conducted to see if the same mechanisms were present 
in experimentally induced models of hypertension.
Two models of experimental hypertension were looked at; 
the Goldblatt, two-kidney, one-clip renal hypertensive rat 
and oestrogen-induced hypertension. To this effect it was 
found that the presynaptic P 2 ”adrenoreceptor-mediated 
facilitation of vascular adrenergic neurotransmission was 
enhanced in the experimental models of hypertension 
compared to control normotensive rats. However, the 
enhanced presynaptic All-receptor-mediated facilitation of 
vascular adrenergic neurotransmission was only found in 
preparations from the renal hypertensive rat.
Plasma adrenaline and noradrenaline levels were elevated 
in all models of hypertension compared to that in 
normotensive rats.
It therefore seems that sympatho-adrenal activity plays an 
important role in the development and maintenance of 
hypertension.
It yet remains to be seen as to what causes the onset of 
genetic hypertension.
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2This thesis is concerned with the enhanced facilitation of 
adrenergic neurotransmission in isolated perfused vascular 
preparations from genetically hypertensive rats and
experimentally hypertensive rats compared to that in 
normotensive rats.
The hypothesis that adrenergic nerve terminals possess 
^-adrenoreceptors which facilitate transmitter release is 
relatively new (Adler-Graschinsky and Langer, 1975; 
Stjarne and Brundin, 1975; Hedqvist and Moawad, 1975) but, 
as so often happens with hindsight earlier observations 
pointing that way can be found. Experimentally the
hypothesis is based on the ability of Ji-adrenoreceptor 
agonists to increase and of £-adrenoreceptor antagonists 
to decrease the amount of transmitter released by nerve 
stimulation. In early experiments on the depression by 
catecholamines of transmission through autonomic ganglia 
it was noted that in low concentrations adrenaline and 
especially isoprenaline facilitated rather than depressed 
transmission (Matthews, 1956; Pardo et al 1963). A
similar facilitatory effect of isoprenaline on the release 
of a transmitter, this time acetylcholine from field- 
stimulated guinea-pig longitudinal muscle preparation, was 
reported previously (Paton and Vizi, 1969).
%
The evidence that jS-adrenoreceptor antagonists could 
depress responses to adrenergic nerve stimulation, even in 
tissues where the postsynaptic receptors were alpha 
-adrenoreceptors, was particularly clear; in the first
3report (Day et al, 1968) propranolol was shown to be as 
effective as guanethidine in reducing the response to 
sympathetic nerve stimulation in the rat vas-deferens, the 
rabbit ileum and the perfused rabbit ear artery. Like 
guanethidine, propranolol potentiated the response to 
noradrenaline (NA). The effect did not seem to be caused 
by the known local anaesthetic action of propranolol since 
a ten-fold higher concentration of lignocaine was 
ineffective. Lignocaine and propranolol are about 
equiefficative as local anaesthetics (Morales-Aquilera and 
Williams, 1965). This ability of propranolol to block 
nerve responses was confirmed and extended to other 
similar drugs and other tissues such as the guinea-pig vas 
deferens (Mylecharane and Raper,1970), the cat nictitating 
membrane (Eliash and Weinstock, 1971) and spinal 
vasoconstrictor nerves (Ablad et al, 1970). Propranolol 
for a time was regarded as an adrenergic neurone blocker, 
though its action was mediated through JS-adrenoreceptors, 
since its neurone blocking activity did not correlate with 
postsynaptic ^-adrenoreceptor blockade (Mylecharane et al, 
1970, Eliash et al, 1971).
Adler-Graschinsky and Langer (1975) first suggested that 
the release of NA from sympathetic nerve endings might be 
modulated by presynaptic p-adrenoreceptors through a 
positive feedback mechanism. They used isolated guinea- 
pig atria and demonstrated that isoprenaline increased the 
stimulation-induced overflow of NA whereas propranolol 
decreased this overflow. A facilitatory effect of
4isoprenaline on stimulation-induced overflow of NA has 
been shown in other tissues: in cat aorta and nictitating 
membrane (Langer et al, 1975); rat cerebral cortex 
(Farnebo and Hamberger, 1974); guinea-pig atria (Rand et 
al, 1976); human omental arteries and veins (Stjarne, _ 
1975; Stjarne and Brundin, 1976).
Nerve impulses in most sympathetic nerves elicit a 
response in the effector cell (e.g. smooth muscle) by 
releasing the chemical transmitter NA, which affects 
specific receptor sites on the effector cells (& - or J3- 
adrenoreceptors). The amount of NA released, and
therefore the degree of response elicited, is ultimately
under the control of the central nervous system, which 
controls the amount and rate of delivery of nerve
impulses. However, there is now a substantial body of 
evidence suggesting that there are peripheral receptor- 
mediated mechanisms which can modulate the amount of NA 
released by each nerve impulse.
Inhibition of the induced release of endogenous NA has 
been observed with NA and other^-adrenoreceptor agonists.
In addition, acetylcholine, choline, dopamine, 
prostaglandin E 2 , adenosine, histamine and 5-
hydroxytryptamine have also been shown to inhibit the 
release of endogenous NA (Westfall, 1977, Starke, 1977).
On the other hand there have been reports of enhanced 
release of stimulation-induced NA by agents that activate 
angiotensin II (All) receptors (Kawasaki et al 1982b),
5^-adrenoreceptor agonists (Stjarne and Brundin, 1975; 
(Kawasaki et al, 1982a, 1984) and nicotinic agonists
(Westfall and Brasted, 1974).
The experiments with £-adrenoreceptor agonists have given 
rise to the hypothesis suggesting that the release of NA 
may be subject to a positive feedback modulation in 
addition to the well-established presynaptic 
CK-adrenoreceptor-mediated negative feedback mechanism 
(Starke, 1974b, 1975b). According to the hypothesis, the 
positive feedback mechanism would be activated by low 
concentrations of the transmitter, NA, leading to an 
increase in the release of the transmitter per impulse. 
As the concentration of the NA in the synapse increases, 
the positive feedback would then be replaced by the 
negative feedback process mediated by the presynaptic 
OC-adrenoreceptor (Adler-Graschinsky et al, 1975). The 
terms presynaptic, or prejunctional, have been coined to 
indicate that these release-modulating receptors are 
located before the neuro-effector junction (Starke and 
Langer, 1980), that is to say, on or next to the terminal 
varicosities of the post ganglionic nerve ending. 
However, exogenous NA has only been shown to increase 
transmitter NA release when presynaptic (Xradrenoreceptors 
are blocked. An alternative hypothesis (Stjarne and 
Brundin, 1976) suggests that the physiological role of 
presynaptic J5-adrenoreceptors may be to detect
circulating adrenaline (Ad) from the adrenal medulla 
rather than NA from sympathetic nerve terminals, during
conditions of stress, Ad released from the adrenal medulla 
would thus increase sympathetic nerve activity. 
Furthermore, it has been demonstrated, in isolated guinea- 
pig atria, that ji-adrenoreceptor antagonists consistently 
reduced transmitter NA release when Ad was incorporated 
into the transmitter stores along with NA, but failed to 
do so when only NA was present (Rand et al, 1979), This 
suggests that transmitter NA does not facilitate its own 
release by activating a positive feedback loop through 
presynaptic B-adrenoreceptors; however, if adrenaline is 
also present, the facilitatory mechanism is activated. It 
is conceivable that Ad, taken up from the circulation and 
incorporated into transmitter stores of noradrenergic 
axons, is released on stimulation along with NA and 
activates the positive feedback mechanism through 
presynaptic p-adrenoreceptors.
Adrenaline can be released as a co-transmitter with NA 
from sympathetic nerves for some time after its initial 
uptake from the circulation since Ad taken up into 
sympathetic nerves has a longer half-life (approximately 
four hours) than in the blood (approximately one minute) 
(Majewski et al, 1981a). Ad facilitation of NA release 
has been shown in the anaesthetized rabbit (Majewski et 
al, 1982a) where Ad administration caused an increase in 
the rate of NA release into the plasma. This occurred 
after the Ad had disappeared from the plasma, but at a 
time when the Ad levels in sympathetically-innervated 
tissues were raised. Pretreatment of the rabbits with
desipramine to block neuronal uptake, or propranolol to 
block p-adrenoreceptors, prevented the facilitatory effect 
of Ad. This suggests that the neuronally-released 
adrenaline can activate presynaptic p-adrenoreceptors to 
facilitate NA release in vivo. Indeed, it has been 
demonstrated that Ad is a hundred times more potent than 
NA in enhancing the release of NA from sympathetic nerves 
(Dahlof et al, 1978). Thus, it seems that Ad rather than 
NA may be of physiological importance in the activation of 
this positive feedback mechanism.
Lands et al (1967) proposed that p-adrenoreceptors could 
be divided into two sub types, p^- or P 2 ~adrenoreceptors> 
according to the rank order of potency of a series of 
agonists. Attempts have been made to characterize the 
presynaptic p-adrenoreceptors in terms of these 
postsynaptic p-adrenoreceptor subtypes. Stjarne and 
Brundin (1976), using relatively selective p^- and P 2 - 
adrenoreceptor agonists and antagonists, concluded that in 
human omental arteries and veins the presynaptic receptors 
were of the P 2 *-subtype. Similar results have been 
obtained in the rat portal vein (Dahlof et al, 1978 
; Westfall et al, 1979).
However, not all experiments have yielded clear results. 
In the guinea-pig atria, neuronally-released Ad but not 
neuronally-released NA facilitated the stimulation-induced 
release of NA, suggesting that the presynaptic 
p-adrenoreceptors are of the p 2 -subtype. Similarly in rat
8isolated atria in the presence of phenoxybenzamine, Ad, 
but not NA, enhanced the stimulation-induced efflux of NA. 
Again, this indicates the presence of P2"ac^ renoreceP tors> 
however metoprolol reduced the facilitatory effect of Ad 
(Majewski et al, 1981b).
Further, in human digital arteries the B 2 ~adrenoreceptor 
agonist, salbutamol, was more potent than the selective 
B^-adrenoreceptor agonist, dobutamine, in enhancing the 
stimulation-induced efflux of NA (Stevens et al, 1982).In 
the isolated mesenteric vasculature it has been shown that 
butoxamine, a selective B2“ac^ renoreceP tor antagonist, 
reduced the isoprenaline-induced potentiation of the 
pressor response to periarterial nerve stimulation 
(Kawasaki et al, 1982a).
On the other hand Majewski et al ( 1981b,
1982b) have shown that metoprolol reduces the increase in
blood pressure due to adrenaline implants in normotensive 
rats, thereby indicating that the presynaptic 
B-adrenoreceptor was of the jS^-subtype. Work done 
previously in the guinea-pig pulmonary arteries showed 
that 1-metoprolol and not, d-metoprolol, inhibited
isoprenaline-induced increases in efflux by transmural 
field stimulation (Misu et al, 1983). Metoprolol is
characterised as a relatively selective B^-adrenoreceptor 
antagonist and these results therefore suggest that there 
may exist additional presynaptic B-^-adrenoreceptors in the 
guinea-pig atria (Misu et al, 1983). Further experiments
9conducted by Misu et al (1983) show that acebutolol, 
bevantolol and practolol did not antagonize, whereas 
metoprolol, butoxamine and H35/25 antagonised salbutamol- 
induced increases in impulse evoked 3h efflux supporting 
the existence of presynaptic P 2 ~adrenoreceptors rather 
than of the p^- subtype adrenoreceptor• There is also a 
possibility that presynaptic p-adrenoreceptors might 
differ from postsynaptic classical p-adrenoreceptors, 
probably in the same way as the presynaptic and 
postsynaptic cc-adrenoreceptors differ in their affinity 
for agonists and for antagonists (Langer, 1980). Indeed, 
in terms of potency in blocking P 2 *adrenoreceptors, 
metoprolol is slightly more potent than the 
P 2 *-adrenoreceptor antagonist butoxamine (Minneman, Hedberg 
and Molinoff, 1979). Work done on pA 2  values of 
p-adrenoreceptor antagonists (Harms, 1976) showed that in 
certain situations metoprolol probably behaves as a non- 
selective antagonist on postsynaptic p-adrenoreceptors as 
do propranolol and pindolol.
Therefore, the results using agonists in all cases suggest 
that the presynaptic p-adrenoreceptor is of the p 2 -subtype 
but the results with the p-adrenoreceptor antagonists 
reveal no clear picture; this perhaps relates either to 
the lack of selectivity of these agents or to mixed 
receptor subtypes or to different receptor characteristics 
compared to postsynaptic p-adrenoreceptors.
10
That facilitatory presynaptic p-adrenoreceptors play a 
role in human essential hypertension has been an 
attractive hypothesis considering the important place the 
p-adrenoreceptor antagonists have in antihypertensive 
therapy. It has often been stated that at least part of 
the antihypertensive effect of this group of drugs results 
from a sympatho-inhibitory effect caused by blockade of 
presynaptic p-adrenoreceptors (Adler-Graschinsky, 1975;
Majewski et al, 1981b). This hypothesis presumes that 
presynaptic p-adrenoreceptors are activated by some 
physiological agonist, and Ad seems to be the prime 
candidate for this role considering its effects on 
presynaptic p-adrenoreceptors.
One test of this hypothesis is whether high blood pressure 
develops when the Ad input into the circulation is 
chronically or intermittently increased. Studies in rats 
where Ad was given as a slow release preparation (Majewski 
et al, 1981b), incorporated into osmotic mini pumps 
(Majewski et al, 1982b; Borkowski and Quinn, 1985), showed 
that sustained increases in blood pressure did develop and 
these increases were prevented by concomitant treatment 
with a p-adrenoreceptor antagonist.
The Spontaneously Hypertensive (SH) rat (Okamoto and Aoki, 
1963) has been widely used as a model for studying human 
essential hypertension (Grollman, 1972). However the 
actual mechanisms underlying the development and/or 
maintenance of hypertension in the SH rat remains
11
uncertain. The results from an investigation carried out
by Mulvany on the resistance vessel abnormalities in the
SH rat (Mulvany, 1984) indicate that the heart/body weight
ratio and the media/lumen ratio of the resistance vessels
are increased in the twelve to fourteen week old SH rat
compared to age matched normotensive rats. It is
suggested that this is due primarily to genetic factors
rather than to the increased blood pressure, and these
structural abnormalities do not appear to be a sufficient
cause of the increased blood pressure. The calcium
sensitivity of resistance vessels, which is also increased*
in the SH rat, may be associated with the genetic factors 
responsible for the increased blood pressure (Mulvany, 
1984).
Another hypothesis postulates an increased total vascular 
resistance resulting from enhanced sympathetic adrenergic 
nerve tone as the cause of increased blood pressure in the 
SH rat (Iriuchima, 1973; Hallbeck and Folkow, 1974; Judy
et al, 1976; Nagatsu et al, 1976; Coote and Sato, 1977;
Cheng and Shibata, 1980). This increased adrenergic tone 
in the SH rat may be due in part to an increased
facilitatory and/or a decreased inhibitory modulation of 
adrenergic neurotransmission.
Indeed, previous reports (Kawasaki et al, 1982a) have 
indicated that in the isolated mesenteric vasculature of 
the SH rat an increased modulation of the facilitatory
presynaptic p-adrenoreceptor exits. This indicates that
12
the increased adrenergic tone in the SH rat may be due in 
part to enhanced facilitatory presynaptic p- 
adrenoreceptor-mediated modulation of the adrenergic 
neurotransmission.
Basal plasma Ad and NA levels in the SH rat are not 
different compared to normotensive Wistar-Kyoto rats but 
stress-induced release of Ad and NA into the circulation / 
is significantly higher in the SH rat compared to that in 
the Wistar-Kyoto rat (McCarty et al, 1978). This increase 
in plasma Ad could, it is postulated, activate the 
presynaptic p-adrenoreceptor and thereby cause an 
increased adrenergic vascular tone in the SH rat. 
However, it has been shown that propranolol has an acute 
antihypertensive effect in the absence of circulating Ad 
in bilaterally adrenalectomised Wistar-Kyoto rats made 
hypertensive with methylprednisolone (Burris et al, 1984).
The results of the work carried out by Burris et al (1984) 
indicate that propranolol reduces blood pressure at least 
in part by mechanisms other than presynaptic 
p-adrenoreceptor blockade. There is evidence for a 
central site of action of propranolol (Alexander et al, 
1975; Garvey et al, 1975; Day et al, 1973; Reid et al, 
1974) and this could account for the propranolol-induced 
reduction of central sympathetic activity. Finch and 
Leach (Finch et al, 1970) have shown that the development 
of renal and DOCA/NaCl hypertension in the rat was 
unaffected by demedullation and that chemical 
sympathectomy using 6-hydroxydopamine followed by
13
demedullation also failed to prevent the development of 
these types of hypertension. The results of the work of 
Finch et al (1970) suggest that experimental hypertension 
in the rat is independent of the adrenal medulla provided 
an adequate salt intake is maintained.
However, bilateral adrenal demedullation of young SH rats 
has been shown to attenuate the development of 
hypertension and to reduce significantly vascular 
responses to sympathetic nerve stimulation (Borkowski and 
Quinn>1983).
Besides the involvement of adrenergic and adrenal medulla 
in the development and/or maintenance of hypertension 
described above another mechanism may contribute to the 
increased vascular tone, and therefore result in elevated 
vascular resistance, in SH rats and in other animal models 
of hypertension, and this is the renin-angiotensin system. 
The role of the renin-angiotensin system in blood pressure 
maintenance is unsettled. Studies with radioactive 
angiotensin II (All) indicate that this octapeptide is 
bound to specific receptor sites in vascular smooth muscle 
(Baudoin et al, 1971). This suggests that renin, through 
angiotensin, has a specific function in this tissue 
(rabbit aorta). However, in chronic renal hypertension 
and in spontaneous hypertension in rats (Okamoto and Aoki, 
1963) the relationship of renin to elevated blood pressure 
has been questioned because of the observation that 
circulating renin is normal or low compared to
14
normotensive animals (Koletsky et al, 1967; Vincent et al, 
1976). On the other hand, others (deJong et al, 1972) 
have reported that renin increases with age in SH rats.
Renin is known to be present in the blood vessel walls of 
pigs and rats (Dengler, 1956; Rosenthal et al, 1969) and 
thus might play a role in blood pressure maintenance. 
Injection of anti renin into dogs with either acute renin- 
induced hypertension or chronic one-kidney Goldblatt renal 
hypertension caused a rapid, partial drop in blood 
pressure during the first twenty minutes after infusion in 
the first model and a much slower drop (4 to 10 days) in 
the second. The rate of production of the hypotensive 
effect is consistent with the hypothesis that 
neutralization of circulating renin occurred in the 
acutely hypertensive animals and of vascular wall renin in 
chronically hypertensive ones (Hill et al, 1970).
In the rat, the action of an angiotensin II antagonist, 
which can penetrate the arterial wall and angiotensin II 
antiserum, which cannot, suggested that renin generates 
angiotensin at a local vascular level at a site not 
readily accessible to antiserum (Thurston and Swales, 
1974). Additional support for this theory is that 
converting enzyme inhibitor causes a fall in blood 
pressure for several hours after bilateral nephrectomy, 
indicating that the renin-angiotensin system maintains 
blood pressure in this model even after plasma renin has 
fallen to insignificant levels (Thurston et al, 1977). In
15
addition the pressor action of renin is present in 
nephrectomised animals without detectable circulating 
renin (Schaechtelin et al, 1964), Considerable evidence 
implicates the sympathetic nervous system and the 
catecholamines in the regulation of renin secretion 
(Vander, 1965; Gordon et al, 1967). In view of the close 
relation of adrenergic nerve endings to juxtaglomerular 
cells (Wagermark et al, 1968) and the release of renin 
from renal cortical cell suspension (Michelakis et al, 
1969), a direct effect of adrenergic hormones on renin 
secretion seems likely. The suggestion that renin 
secretion provoked by catecholamine infusion or 
sympathetic nerve stimulation is mediated by p- 
adrenoreceptors receives support from studies in dogs 
(Ganong, 1972; Tanigawa et al, 1972) and man (Michelakis 
et al, 1972), using adrenoreceptor antagonists.
There is evidence that all the components of the renin- 
angiotensin system are present in the mesenteric 
vasculature of the rat (Desjardins-Giasson et al, 1981). 
In addition, there have been reports that utilization of 
renin substrate within the mesenteric vascular wall of 
rats by renin, or renin-like enzymes, resulted in the 
formation of angiotensin I, which was then converted to 
angiotensin II. The locally-generat&d angiotensin II was 
shown to enhance the vasoconstrictor responses to 
adrenergic nerve stimulation of the mesenteric vasculature 
(Malik et al, 1976).
16
Supporting the suggestion that increased sympathetic 
adrenergic tone in the vasculature of the SH rat, 
postulated to be the aetiology of this hypertension 
(Iriuchijuma, 1973; Judy et al, 1976; Cheng and Shibata, 
1980), may be due to an increased facilitatory and/or 
decreased inhibitory modulation of vascular adrenergic 
neurotransmission, are the reports that the facilitatory 
modulation of vascular adrenergic neurotransmission 
mediated by presynaptic All receptors were enhanced in the 
isolated perfused mesenteric vascular preparation from SH 
rats (Eikenburg et al, 1981; Kawasaki et al, 1982b; Clough 
et al, 1982) and also in the in situ, blood-perfused 
mesentery of SH rats (Cline, 1982; 1983). A variety of 
changes in other modulatory mechanisms in several vascular 
beds has been reported to occur in the SH rat, with most 
of these reported changes supporting increased release of 
NA (Kamikawa et al, 1980; Lokhandwala and Eikenburg, 
1983).
It is well documented that a ^-adrenoreceptor agonist, 
such as isoprenaline, can stimulate the release of renin 
from the kidney and elevate plasma renin activity in vivo 
(Keeton and Campbell, 1980). This in turn would lead to 
the production of All.
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The aims of this thesis are:-
i) To determine whether in the SH rat and the
New Zealand Hypertensive (NZH) rat (Phelan, 
1968) there exists an enhanced presynaptic 
p-adrenoreceptor-mediated facilitation of 
adrenergic neurotransmission in the vascular 
preparations compared to that in normotensive 
Wistar rats and New Zealand Normotensive (NZN) 
rats.
ii) To investigate if facilitatory presynaptic 
p-adrenoreceptors are present in the rats, the 
nature of the p-adrenoreceptor i.e. whether it 
is of the p^- or P 2 ~subtype.
iii) Furthermore, the involvement of the vascular 
renin-angiotensin system in p-adrenergic 
receptor-mediated facilitation of vascular 
neurotransmission in rats is investigated, 
especially in regard to enhanced angiotensin II- 
receptor-mediated facilitation of adrenergic 
neurotransmission in the vasculature of the 
hypertensive rat
iv) The involvement of the above two presynaptic-
receptor-mediated effects on the modulation of 
adrenergic neurotransmission in vascular 
preparations from experimentally-induced
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hypertensive Wistar rats is also investigated. 
Two methods of inducing experimental 
hypertension in the Wistar rats were employed. 
They were:-
a) Mechanical occlusion of the renal artery to 
induce renal hypertension; the "two-kidney, 
one-clip renal hypertensive*1 rat (Goldblatt 
et al, 1934), and
b) Chemically-induced hypertension by treating 
the Wistar rats chronically with 
ethinyloestradiol.
The ultimate aim of this thesis is to show if facilitatory 
presynaptic p-adrenoreceptor and presynaptic All receptor 
are enhanced in hypertensive rats and that this 
enhancement is in part responsible for the increased 
vascular tone in the animals which is indicated in the 
development and/or maintenance of the hypertension.
In order to investigate the subtype of the
p-adrenoreceptors, a selective P 2 -adrenoreceptor 
antagonist, ICI 118,551, was employed in the experiments. 
Previously described P 2 “se^ect:*-ve antagonists such as 
butoxamine, H35/25 and IPS 339 are lacking in potency, 
specificity, or appropriate P 2 *selectivity. ICI 118,551 
possess a high degree of selectivity and specificity for 
the P2“a<^ renorecePtor (Bilski et al, 1983). The £ 2 ^ 1 ”
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selectivity ratios, in vitro, are 123 for ICI 118,551 and 
2,2 for propranolol (Bilski et al, 1983). ICI 118,551 has 
no partial agonist activity but has a membrane-stabilising 
action similar to that of propranolol (Bilski et al, 
1983). Since in the Goldblatt, two-kidney, one-clip renal 
hypertensive rat the level of circulating renin is 
elevated and is accompanied by an increased concentration 
of renin in the arterial walls (Garst et al, 1978) and 
since the sympathetic nervous system is also implicated in 
this type of hypertension (Laverty et al, 1961; McCubbin 
et al, 1963), the effect of ICI 118,551 on the induced 
hypertension was also investigated.
Plasma levels of Ad and NA were also monitored in SH rats, 
Wistar rats and all the forms of experimentally-induced 
hypertensive rats.
In the next five chapters, the methods and results of 
various investigations are shown followed by a short 
discussion of the results at the end of each relevant 
chapter. A fuller and more concise discussion is in the 
"Discussions" chapter (Chapter 7)
20
CHAPTER 2
ISOLATED PERFUSED MESENTERIC VASCULATURE
2.1 Preliminary work
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The isolated mesenteric vasculature was set up as 
described below and perfused with oxygenated Krebs. Ideal 
parameters for peri-arterial nerve stimulation (PNS) in 
order to give consistent and repeatable pressor responses 
were found to be 30Hz, 80V, 1msec pulse width for 10
seconds. Unlike Kawasaki et al (Kawasaki et al, 1982a, 
1982b, 1984), I found that if too low a frequency was
used, i.e. below 20Hz, and duration of the stimulation 
period increased to over 15 seconds, the preparation would 
not respond consistently to the PNS and the preparation 
would not last for more than 20 to 30 minutes. Kawasaki et 
al, 1982a, 1892b, 1984) used 10Hz for 30 seconds giving a 
total of 300 impulses. Therefore the total number of 
impulses delivered to the tissue per PNS period was 
similar in both our protocols.
Next, a concentration of NA necessary to give an increase 
in perfusion pressure of the preparation roughly similar 
to that caused by PNS (30Hz, 80V, 1msec, lOsec) was
determined; this concentration was found to be 0.1ml of a 
10”6m solution of noradrenaline bitartarate.
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2.2 Methods
2.2i Isolated perfused mesenteric vascular bed
The rats were killed by first stunning and then 
dislocating the cervical vertebrae. The isolated 
mesenteric vascular bed was prepared essentially by the 
method of McGregor (McGregor, 1965). Briefly a ventral 
midline incision was made through the skin and body wall 
from the lower abdomen to the xiphis ternum. The 
intestines were reflected to the left and the superior
mesenteric artery was freed approximately 1 cm. distal to 
its bifurcation from the aorta and ligated. A portex 16 
gauge (3 FG) polyethylene cannula, outer diameter 1.02 mm, 
was inserted into the superior mesenteric artery and the 
blood was gently flushed out with 10 ml of the Kreb's
solution. The pancreaticoduodenal, ileocolic, colic and 
caecal branches of the superior mesentery artery were tied 
off as were all branches of the latter supplying the ileum 
except the four most distal divisions. The mesenteric 
vascular bed was freed from the intestines by cutting
close to the border with the intestines. During the 
dissection, care was taken to keep the mesenteric
vasculature moist with oxygenated Kreb's. The isolated 
vasculature was placed in a 5 ml water-jacketed organ bath 
maintained at 37°C and perfused with a modified Kreb's 
solution at a constant flow rate of 5 ml/min by means of a 
Watson Marlow peristaltic pump. The modified Kreb's was 











The perfusing solution was aerated with a mixture of 95% 
oxygen and 5% carbon-dioxide before passing through a 
warming coil maintained at 38°C. Changes in perfusion 
pressure were measured at a point close to the cannula by 
means of a pressure transducer (Bell and Howell, type 4- 
422-0001) and recorded on a Devices (M2) recorder.
After allowing time for the basal perfusion pressure to 
stabilize, usually 15 min, the perfused mesenteric 
vasculature was subjected either to periarterial nerve 
stimulation (PNS) or to a bolus of noradrenaline (NA). 
The PNS was delivered at 5 min. intervals via bipolar 
platinum electrodes placed around the superior mesenteric 
artery. Supramaximal rectangular pulses, 1 msec, 80V, 
were applied for 10 sec. at 30Hz by means of a Grass, 
model S44, stimulator. The neural basis of the pressor 
response mediated by stimulation of the arterial 
adrenergic nerve was confirmed in the preparations from 
SHR male and female, NZH female and control animals by 
abolition of the response after perfusion with
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guanethidine (O.OlmM, 11=3 animals for each group). 
Noradrenaline (0.1 ml of 10"^M soln) was injected directly 
into the perfusate proximal to the arterial cannula at 5 
minute intervals.
Once stable responses to PNS or NA infusion had been 
demonstrated, perfusion with the other drugs began. 
Perfusion of B-adrenoceptor agonists and angiotensin II 
(All) was begun 3 min. before and throughout PNS or NA 
infusion. In the experiments involving beta-adrenoceptor 
antagonists the perfusion of the antagonist was begun 10 
, minutes before simultaneous perfusion with the agonist. 
Infusion of the angiotensin II receptor antagonist [Sarl- 
Ile8] angiotensin II (Sar) was started 2 minutes before 
simultaneous perfusion with angiotensin II. I found like 
Kawasaki et al (1982b;. 1984), that the second response 
elicited by PNS when perfusing B- adrenergic receptor 
agonist was greater than the first i.e. the response to 
PNS at 8 minutes from the start of perfusion was greater 
than that at 3 minutes Therefore all the data were 
derived from the second response to PNS or NA infusions
9
during perfusion of the drugs. The exception to this was 
data of responses to PNS or NA infusion from experiments 
involving cocaine. Only one response, at the 8th minute, 
was taken when cocaine was perfused. This was because 
during PNS the first response was much greater than the 
second. This could be explained by the fact that cocaine 
caused blockade of the uptake mechanism, therefore causing 
most of the neurally-released noradrenaline to be washed
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away by the perfusing solution. In the experiments 
involving antagonists, the response to PNS or NA infusion 
before the perfusion of the antagonist was taken as 
control.
PNS and NA response data after drug perfusion in the 
preparations are expressed as a percentage of the control 
pressor response in order to standardize the data.
Male and female Japanese Hypertensive (SH) rats (Okamoto 
and Aoki, 1963) and female New Zealand Hypertensive rats 
(NZH) (Phelan, E.L., 1968) were compared to age matched 
male and female Wistar rats (University of Bath strain) 
and female New Zealand Normotensive rats (NZN) (University 
of Bath strain), respectively. The animals used were 14- 
16 weeks old and were supplied by the University of Bath 
Animal House.
Systolic blood pressure was monitored in the conscious 
animal by the tail-cuff method using a programmed electro­
sphygmomanometer PE-300 (Narco bio-instruments) coupled to 
a flat-bed record (CR-6505, J.J. instruments).
2.2ii Statistical Analysis
Results were analysed using Student*s t-test for group and 
paired mean comparisons. Probability levels equal to or 
less than 0.05 were taken as indicating statistically
26




2.3i Table 2.1 compares the weight, systolic blood / 
pressure, basal perfusion pressure and the pressor 
response to PNS and NA infusion in the six groups of rats.
The mean systolic pressures and the mean pressor responses 
to PNS and NA infusions were found to be significantly 
higher in the hypertensive group than those in their 
respective normotensive controls. The basal perfusion 
pressure was found to be essentially similar in all the 
groups. The males in general were found to be heavier 
than the age-matched females, though no significant 
difference was observed within the two male groups or the 
four female groups.
Besides weight, neither significant sex related 
differences nor strain (i.e. SH female versus NZH female
and Wistar versus NZN) differences were observed between
the groups.
Statistical tests were carried out to determine whether 
there was any correlation between the following parameters 
in each of the groups.
a) Weight and systolic blood pressure
b) Systolic blood pressure and basal perfusion pressure
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Table 2.1
Systolic blood pressure and basal perfusion pressure, pressor 
responses to PNS and NA infusion in isolated mesenteric vascular 
beds from male and female SH (SHRm and SHR*, respectively), male 




















SHR 195 + 5 35 + 3 15.0 + 1.2 18.7 + 0.8m — —
(25) (15) (19) (13)
W 98 + 5 30 + 2 6.9 + 0.4 9.5 + 0.5m
(20) (15) (20) (8)
SHR 185 + 5 4 1 + 4 14.1 + 0.9 21 + 0.17f + *
(25) (20) (20) (13)
Wf 94.2+3 36 + 5 7.2 + 0.6 10.3 + 0.5
(25) (20) (20) (7)
NZH 181*+ 4 33 + 4 12.5 + 1.4 17.4 + 0.6
+ ♦
(25) (20) (20) (13)
NZN 120 + 5 36 + 5 6.6 + 1.2 8.6 + 0.8
(25) (20) (20) (10)
Values are given as mean + s.e. of the mean.
Number in parenthesis - number of animals.
. indicates significant differences between SH., NZH rats 
and respective normotensive rats (p(0.01)
+ indicates signfleant differences between SH, NZH rats 
and respective normotensive rats (p(0.05)a
* indicates significazit differences between SH, NZH rats 
and respective normotensive rats (p(0.001)
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c) Basal perfusion pressure and pressor response to PNS 
and NA infusions
No correlation was found between any of the parameters,
2.3ii Effect of isoprenaline on the pressor 
response to PNS and NA infusion
Isoprenaline alone had no significant effect on the basal 
perfusion pressure of the isolated mesenteric preparation 
from any of the rat groups. In the preparations from the 
SH and NZH rats, isoprenaline caused a dose-dependant 
potentiation of the pressor response to PNS. At lower 
isoprenaline concentrations (10"^M to 5x10"8m ) a smaller 
potentiation of the pressor response to PNS was observed, 
whereas, at the higher isoprenaline concentrations 
(>5xlO“^M) inhibition of the vasoconstrictor response to 
PNS was observed in the normotensive control rats.
Figs 2.1 a,b,c.
A typical trace of the potentiating effect of isoprenaline 
on the PNS response in the hypertensive rat is shown in 
Fig 2.2
As can be seen in Figs 2.3 a,b,c, isoprenaline caused a 
dose dependant inhibition of the pressor response to NA 


























5xl0’9 10”8 5x10~8 10”7 5xl0"7
Isoprenaline concentration (M)
10-6
Effect of Isoprenaline on the pressor response to PNS In the
Isolated perfused mesenteric vasculature of male SH antf (.---.)
and male Wistar (,____») rats.
Vertical lines indicate s.e. of mean, n = 4 animals for the 
SH group and n = 5 animals for the Wistar group 
At all points, SH response significantly greater than Wistar 
response (p<0.05) and control pressor response (p^O.Ol)
+ p(0.05 compared to control pressor response
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 1 1 1 1 1 1 1
10"9 5xicf9 10“8 5x1 o"*8 l(f 7 5xl0~7 10’6
Isoprenaline concentration (M)
Fig 2.1b
Effect of isoprenaline on the pressor response to PNS in the
isolated perfused mesenteric vasculature of female SH (.---.)
and female Wistar (.____) rats.
Vertical lines indicate s.e. of the mean.
n - 5 animals for the SH group and n s 4 animals for the Wistar 
group.
At all points, SH rat responses significantly greater than 
Wistar rat responses (p<0.01) and control responses (p(0.01).



























—9 —Q —8 —8 —7 —7 —6
lo 5x10 10 5x10 10 5x10 10
Isoprenaline concentration (M)
Fig 2.1c
Effect of isoprenaline on the pressor response to PNS in the
isolated perfused mesenteric vasculature of female NZH (®---#)
and female NZN (#___#) rats.
Vertical lines indicate s.e. of the mean, 
n - 4 animals for each group
At all points, NZH rat responses significantly greater than 
control response (p^0.05)
+ p<0.05 compared to control pressor response
. p<0.05 compared to NZH rat
* p<0.05 compared to NZN rat
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—8Iso 5x10 MKrebs Iso 10 M
70
40
Iso 10“7M Iso 5x10 ?M
Fig 2.2. Typical trace of the facilitatory effect of
Isoprenaline (Iso) on the pressor response to 
periarterial nerve stimulation in the isolated 
perfused mesenteric vasculature from female SH rat.
Data dervied from the second response to 






























-7 -710 5x10 10-6
Effect of isoprenaline on the pressor response to NA infusion
in the isolated perfused mesenteric vasculature of male SH (•---•)
and male Wistar (•___.) rats.
Vertical lines indicate s.e. of mean (most omitted for clarity), 
n = 4 animals for each group.
-9 -6Responses from 5 x 10 M to 10 M isoprenaline significantly 




















-9 -9 -8 -8 -7 -7 -610 5x10 10 5x10 10 5x10 10
Isoprenaline concentration (M)
Fig 2.3b
Effect of Isoprenaline on the pressor response to NA infusion 
in the isolated perfused mesenteric vasculature of female 
SH (•-- «) and female Wistar (*___*) rats.
Vertical lines indicate s.e. of the mean. Most omitted for clarity 
n = 4 animals for the SH group and n = 3 animals for the Wistar 
group. _9 _6
Responses from 5 x 10 M to 10 M isoprenaline significantly 



























Effect of isoprenaline on the pressor response to NA infusion 
in the isolated perfused mesenteric vasculature of female NZH 
(.-- .) and female NZN (.---  ) rats.
Vertical lines indicate s.e. of the mean. Most omitted for clarity 
n = 4 animals for each group.
-9 -6
Responses from 5 x 10 M to 10 M isoprenaline significantly 
different from control pressor response (p<0.05)
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There was no significant difference in the degree of 
inhibition of the NA pressor response between the 
hypertensive and respective normotensive rats, however, 
the degree of the isoprenaline induced potentiation of the 
PNS pressor response was significantly higher, at all 
isoprenaline concentrations, in the hypertensive rats than 
in the respective normotensive rats.
In order to investigate the effects of JS-adrenoreceptor 
antagonists, a standard concentration of 5xlO”^M 
isoprenaline was chosen, since this was the concentration 
that in control animals produced the greatest potentiation 
of the PNS pressor response.
2.3iii Effect of non selective beta adrenoreceptor
antagonist on the isoprenaline induced effects on 
the pressor responses to PNS and NA infusions
Propranolol (5x 10“8m ) was used as the non selective jS- 
adrenoreceptor antagonist. At the concentration employed 
in this study, propranolol alone had no significant effect 
on the basal perfusion pressure when it was perfused 
through the preparation. Propranolol alone did not 
significantly affect the pressor response to PNS in any of 
the preparations but significantly inhibited the 
isoprenaline induced potentiation of the PNS pressor 


























Prop Iso + Prop
Effect of propranolol (Prop) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of SH, Wistar, NZH and NZN rats.
Male SH rat □ n=8 Male Wistar rat □
Female SH rat B n=8 Female Wistar rat
Female NZH rat n=4 Female NZN rat ■
n=4
n=4
Vertical lines indicate s.e. of the mean, 
n - number of animals for each group.
All groups in Iso section significantly different from control 
pressor response (p(0.05) and all other sections (p<0.05).
+ p<0.05 compared to respective normotensive animal.
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Propranolol (5xlO“^M) by itself caused a moderate 
enhancement of the pressor response to NA infusion in all 
the rat groups* This enhancement, however, was not 
significant in the female NZN rats. The inhibitory effect 
of isoprenaline on the pressor response to NA infusion was 
significantly reversed by the propranolol in all the 
groups. Fig 2.5.
2.3iv Effect of selective ft^-adrenoreceptor
antagonist on the isoprenaline induced effect on 
the pressor responses to PNS and NA infusion
Atenolol (10“7m ) was employed as the selective 
adrenoreceptor antagonist. At this concentration the 
atenolol had no significant effect on either the basal 
perfusion pressure or the pressor response to PNS in any 
of the preparations. Atenolol did not inhibit the 
isoprenaline induced potentiation of the pressor response 
to PNS in any of the preparations. The results indicate 
that atenolol tended to potentiate further the 
isoprenaline induced potentiation of the pressor response 
to PNS in some groups, though this further potentiation 
was significant only in the male SH animals. Fig 2.6
Atenolol (10“^M) alone tended to cause a moderate 
enhancement, about 11% over control, of the pressor 
response to NA infusion in the SH animals. Atenolol 




















Iso Prop Iso + Prop
Fig 2.5
Effect of propranolol (Prop) on the isoprenaline (Iso)-induced 
inhibition of the pressor response to noradrenaline infusion 
in the isolated perfused mesenteric vasculature of SH, Wistar, 
NZH and NZN rats.
Male SH rat 
Female SH rat Q  
Female NZH rat
Male Wistar rat \y\ 
Female Wistar rar f\| 
Female NZN rat H
Vertical lines indicate s.e. of the mean, 
n = 3 animals for each group
-j-p^0.05, for groups in Iso section compared to control pressor 
response and groups in other sections.
+ p<0.05 compared to control pressor response
All groups in Prop section significantly different compared to 





















Iso Aten Iso + Aten
Fig 2.6
Effect of atenolol (Aten) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of SH, Wistar, NZH and NZN 
rats.
Male SH rat □  
Female SH rat B  
Female NZH rat
Male Wistar rat □
Female Wistar rat 
Female NZN rat H
Vertical lines indicate s.e of the mean, 
n = 4 animals for each group.
All groups in isoprenaline section and isoprenaline + atenolol 
section, p(0.05, compared to control pressor response and 
atenolol section.
+ p<0.05 compared to respective normotensive rats 
* p<X).05 compared to isoprenaline alone.
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isoprenaline on the pressor response to NA infusion in the 
preparations from all the groups of rats. Fig 2.7.
2.3v Effect of selective ft^-adrenoreceptor antagonist
on the isoprenaline induced effects on the pressor 
responses to PNS and NA infusions
ICI 118,551 (5x10-7m) was used as the selective £2"
adrenoreceptor antagonist. At this concentration the 
antagonist had no significant effect on either the basal 
perfusion pressure or the pressor response to PNS in any 
of the groups of rats. However, the ICI 118,551 
completely inhibited the isoprenaline induced facilitation 
of the PNS pressor response in the preparations from both 
the hypertensive and control animals. Fig 2.8.
ICI 118,551 significantly inhibited the isoprenaline 
induced inhibition of the pressor response to NA infusion 
in all the preparations. Fig 2.9.
2.3vi Effect of angiotensin II on the pressor response 
to PNS and NA infusion
Angiotensin II (10 ng/ml) tended to produce a transient 
and generally non-significant increase in basal perfusion 
pressure of about 15% in some of the preparations. 
Angiotensin II (All) significantly potentiated the pressor 
response to both PNS and NA infusion in all the groups. 
























Iso Aten Aten + Iso
Fig 2.7.
Effect of atenolol (Aten) on the isoprenaline (Iso)-induced 
inhibition of the pressor response to noradrenaline infusion 
in the isolated perfused mesenteric vasculature from SH, Wistar, 
NZH and NZN rats.
Male SH rat | |
Female SH rat B 
Female NZH rat
Male Wistar rat 
Female Wistar rat f\] 
Female NZN rat
Vertical lines indicate s.e. of the mean, 
n * 3 animals for each group.
-[-p(0.05, for groups in Iso section compared to control pressor 
response and same group in other sections.
























ICI Iso + ICI
Effect of ICI 118,551 (ICI) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of SH, Wistar, NZH and NZN rats
Male SH rat { |
Female SH rat (— )
Female NZH rat
Male Wistar rat 




Vertical lines indicate s.e. of the mean, 
n - 4 animals for each group.
* p(0.05 compared to normotensive rats
. p<0.01 compared to control pressor response and same group in 
other sections























Iso ICI Iso + ICI
Fig 2.9
Effect of ICI 118,551 (ICI) on the isoprenaline CIso)-induced 
inhibition of the pressor response to noradrenaline infusion in the 
isolated perfused mesenteric vasculature from SH, Wistar, NZH and 
NZN rats.
Male SH rat | |
Female SH rat 
Female NZH rat
Male Wistar rat 
Female Wistar rat 
Female NZN rat
Vertical lines indicate s.e. of the mean, 
n - 3 animals for each group.
-f-p(0.05 compared to control pressor response and to groups 
in other sections.
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response was found to be significantly greater in the SH 
and NZH preparations than that in the respective control 
preparations. Fig 2,1.0,
The degree of potentiation caused by the angiotensin II on 
the pressor response to NA infusion was found to be 
essentially similar in all the groups. Fig 2.11.
In the male SH and all the female preparations the degree 
of potentiation of the pressor response to PNS was 
significantly greater than that of the NA infusion 
response (p<0.05).
The specific angiotensin II receptor antagonist, [Sarl- 
Ile^] angiotensin II (Sar, 200 ng/ml), which by itself did 
not significantly effect the basal perfusion pressure and 
the pressor responses to PNS and NA infusion, completely 
prevented the potentiation of the PNS and NA infusion 
responses caused by angiotensin II (10 ng/ml). Fig 2.10. 
and 2.11.
Figs 2.12 and 2.13 shows the effect of cocaine (5 pg/ml), 
which had no effect on the basal perfusion pressure, on 
the pressor response to PNS and NA infusion respectively. 
Cocaine significantly potentiated the pressor response to 
PNS and produced a moderate potentiation of the pressor 
response to NA infusion in the preparations from both the 
hypertensive and normotensive animals. The degree of 






















All Sar All + Sar
Fig 2.10 r 1 8lEffect of angiotensin II (All) and [_Sar -lie J angiotensin II 
(Sar) on the pressor response to PNS in the isolated mesenteric 
vasculature of SH, Wistar, NZH and NZN rats.
Male Wistar rat IZ!
Female Wistar rat
Male SH rat [ 1 








Vertical lines indicate s.e of mean, 
n = number of animals for each group.
. p(0.05, * p^O.Ol compared to control pressor response and 
other sections.






















All Sar All + Sar
Fig 2.11 _
Effect of |_Sar*-Ile^ J angiotensin II (Sar) and angiotensin II (All) 
on the pressor response to noradrenaline infusion in the isolated 
perfused mesenteric vasculature from SH, Wistar, NZH and NZN rats.
Male SH rat | [
Female SH rat |— | 
Female NZH rat
Male Wistar rat 




Vertical lines indicate s.e. of the mean, 
n - 3 animals for each group.
-4-p(0.05 for groups in All section compared to control pressor 






















All Cocaine Cocaine + All
Fig 2.12
Effect of cocaine on the angiotensin II (All)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of SH, Wistar, NZH and NZN rat
Male SH rat □
Female SH rat f— |
Female NZH rat
Male Wistar rat 
Female Wistar rat 
Female NZN rat
Vertical lines indicate s.e of the mean, 
n = 4 animals for each group.
All sections, hypertensive rats compared to respective 
normotensive rats, p(0.01.
+ p<0.05 compared to cocaine section 











































All Cocaine All +_Cocaine
Fig 2.13
Effect of cocaine on the angiotensin II CAII)-induced potentiation 
of the pressor response to noradrenaline infusion in the isolated 
perfused mesenteric vasculature of SH, Wistar, NZH and NZN rats.
Male SH rat Q  Male Wistar rat
Female SH rat |— 1 Female Wistar rar
Female NZH rat Female NZN rat
Vertical lines indicate s.e. of the mean, 
n = 3 animals for each group.
+ p(0.05 compared to cocaine section 




preparations was significantly greater than that in the 
respective control preparations, whereas no significant 
differences between the preparations from hypertensive and 
normotensive animals were observed in the pressor 
responses to NA infusion.
When angiotensin II (10 ng/ml) was administered together 
with cocaine (5 pg/ml),the potentiation of the pressor 
response to both PNS and NA infusion was potentiated 
further and appeared to be additive. The facilitatory 
effect of angiotensin II on the PNS response was greater 
in the SH and NZH than in the Wistars and NZN preparations 
in the presence of cocaine, as well as in its absence.
Thus far these results indicate that, in preparations from 
male and female animals, the vasoconstrictor responses to 
PNS are potentiated by p-adrenoreceptor stimulation and by 
activation of angiotensin II receptors and that this 
potentiation is greater in the SH and NZH animals than in 
the Wistars and NZN animals. The next series of 
experiments explore the relationship between the 
adrenoreceptor and the angiotensin II receptor.
2.3vii Effect of captopril on the isoprenaline induced 
effects on the pressor responses to PNS and NA 
infusion
Captopril (5xlO“^M) alone had no significant effect on the 
basal perfusion pressure or the pressor response to PNS
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and NA infusion. However, captopril effectively inhibited 
the isoprenaline induced potentiation of the pressor 
response to PNS in all the preparations, whilst not having 
any significant effect on the isoprenaline induced 
inhibition of the pressor response to NA infusion in any 
of the preparations. Figs 2.14 and 2.15.
2.3viii Effect of [Sar^-Ile^] angiotensin II on the 
isoprenaline induced affects on the pressor 
responses to PNS and NA infusions
Sar (200 ng/ml) alone had no significant effect on the 
basal perfusion pressure or the pressor response to PNS 
and NA infusion. However, Sar effectively inhibited the 
isoprenaline induced potentiation of the pressor response 
to PNS in all preparations, whilst not having any 
significant effect on the isoprenaline induced inhibition 
of the pressor response to NA infusion in any of the 
preparations. Figs 2.16 and 2.17.
2.3ix Effect of ICI 118,551 on the angiotensin II
(100 ng/ml) potentiation of the pressor response to 
PNS and NA infusion
As shown earlier (Fig 2.8 and 2.9), ICI 118,551 (5x10**7m) 
alone had no significant effect on the basal perfusion 
pressure or pressor responses to PNS and NA infusions. As 
shown in Fig 2,. 18 and 2.19 ICI 118,551 had no 
significant effect on the angiotensin II potentiation of
53
the pressor responses to PNS and NA infusion in any of the 

























Capt Capt + Iso
Effect of captopril (Capt) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vascul,ature from SH,Wistar, NZH and NZN rats
Male SH rats □
Female SH rats B
Female NZH rats
Male Wistar rats 
Female Wistar rats 
Female NZN rats
Vertical lines indicate s.e. of the mean, 
n = 4 animals for each group.
All groups in Iso section significantly greater than groups 





































Effect of captopril (Capt) on the Isoprenaline (Iso)-induced 
inhibition of the pressor response to noradrenaline infusion 
in the isolated perfused mesenteric vasculature of Sti, Wistar, 
NZH and NZN rats.
Male SH rats { |
Female SH rats 
Female NZH rats
Male Wistar rats 
Female Wistar rats 
Female NZN rats
Vertical lines indicate s.e. of the mean, 
n = 3 animals for each group.
-|-p^0.05, for groups in Iso and Iso + Capt section compared to 































r i 8“|Effect of[_Sar -He J angiotensin II (Sar) on the isoprenaline (Iso)- 
induced potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature from SH, wistar, NZH and NZN rats.
Male SH rat | |
Female SH rat B
Female NZH rat
Male Wistar rat 




Vertical lines indicate s.e. of the mean, 
n = 3 animals for each group.
All groups in Iso section significantly different to control 
pressor response and to groups in other sections (p<0.05).



































Effect o f ^ - I l e f ]  angiotensin II (Sar) on the isoprenaline (Iso)- 
induced inhibition of the pressor response to noradrenaline infusion 
in the isolated perfused mesenteric vasculature of SH, Wistar,
NZH and NZN rats.
Male SH rat 




Male Wistar rat 
Female Wistar rat 
Female NZN rat
Vertical lines indicate s.e. of the mean, 
n - 3 animals for each group.
-l-p<P*05, for groups in Iso and Iso + Sar section compared to Sar 


























ICI All + ICI
Effect of ICI 118,551 (ICI) on the angiotensin II (All)- Induced 
potentiation of the pressor response to PNS in the isolated 






Male Wistar rat 0
Female Wistar rat F\|
Female NZN rat
Vertical lines indicate s.e. of the mean, 
n = 3 animals for each group.
_|_p<0.05, groups in this section compared to other sections, 
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Fig 2.19
Effect of ICI 118,551 (ICI) on the angiotensin II CAII)- 
induced potentiation of the pressor response to noradrenaline 
infusion in the isolated perfused mesenteric vasculature of 
SH, Wistar, NZH and NZN rats.
Male SH rat 




Male Wistar rat \/\
Female Wistar rat f\|
Female NZN rat H
Vertical lines indicate s.e. of the mean, 
n = animals for each group.
_j_p^0.05, for groups in ICI section compared to other sections.
2.4 Discussion
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The results described in this chapter suggest that 
physiological mechanisms facilitating sympathetic 
neurotransmission in the mesenteric vascular bed are 
enhanced in the hypertensive rats compared to the 
normotensive controls. This facilitation seems to be 
qualitatively and quantitatively similar in male and 
female SH rats and in female NZH rats. That the 
facilitatory mechanisms are located preynaptically can be 
inferred from the comparison of the effects of 
isoprenaline and angiotensin II on the pressor responses 
to PNS and to infused exogenous NA. It can be further 
concluded that the augmentation of presynaptic activity by 
isoprenaline is mediated via ^2"a<^ renoreceP tors • The 
results also imply that the sequence of events is first 
the activation of a local renin-angiotensin system 
following ^2"ac^ reTloreceP tor stimulation, rather than vice 
versa, and suggesting that a local renin-angiotensin 
system, is involved in mediating £ 2 “a(*renoreceptor 
mediated events via presynaptic angiotensin II receptors 
in the mesenteric vascular bed.
Both the local facilitatory systems are measurably more 
sensitive in the SH and NZH preparations than in the 
Wistar and NZN preparations and are equally marked in both 
male and female animals.
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The preparations from NZH rats seem to be less sensitive 
to the effects of cocaine than preparations from SH rats. 
This could imply that in the vascular preparations from 
NZH rats there may be a less cocaine-sensitive mechanism 
for the uptake of NA and that this could account for the 
increased vasoconstriction found in the NZH rat compared 
to that in the NZN rat.
The next chapter is devoted to a series of experiments 
conducted in a different tissue to see whether the 
findings reported in this chapter are generally applicable 






The isolated kidney was set up as described below and 
perfused with oxygenated Krebs. However, I found that the 
preparation did not respond consistently to PNS for more 
than 30 minutes. Tyrode solution was substituted in place 
of Krebs and it was found that the kidney preparation 
responded consistently to PNS for over 60 minutes. The 
isolated kidney seemed more sensitive to PNS when Tyrode 
was perfused through it than when Krebs was used.
\
Ideal parameters for PNS in order to give consistent and 
repeatable pressor responses were found to be 3Hz, 50V, 1 
msec pulse width for 5 seconds. Next, a concentration of 
NA necessary to give an increase in perfusion pressure of 
the preparation roughly similar to that caused by PNS 
(3Hz, 50V, 1msec, 5sec) was determined; this concentration 




3.2i Isolated perfused rat kidney
The rats were anaesthetised with an intra-peritoneal 
injection of pentobarbitone sodium (0.1ml of 6% W/V 
solution per lOOg body weight). An abdominal incision was 
made in the midline, extended ventrally and laterally, and
the intestines were reflected to the left. The right
kidney and major abdominal vessels were exposed by 
clearing away the fat and perivascular tissue by blunt 
dissection. The aorta was gently separated from the 
inferior vena cava around the area of the bifurcation of 
the right renal artery from the aorta. The right renal 
artery was also gently freed from the right renal vein. 
Care was taken not to damage the renal nerves, and the 
renal vasculature was kept moist with oxygenated Tyrode 
solution.
The adrenal branch of the right renal artery was tied and 
loose ligatures were placed around the following blood 
vessels:-
(1) the superior mesenteric artery, near the aorta
(2) the aorta, above the bifurcation of the superior
mesenteric artery.
(3) the right renal artery, near the aorta.
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In addition, cotton thread was passed around the inferior 
vena cava, near the bifurcation of the right renal artery, 
and the right renal vein. This was done so that the vena 
cava and the right renal vein could be gently pulled away 
from the aorta and the right renal artery respectively, 
prior to cannulation of the right renal artery.
Next, the ligature round the mesenteric artery was tied 
off followed by the aortic ligature. As soon as the 
aortic ligature was tied a small incision was made in the 
aorta at the point of the right renal artery’s bifurcation 
from the aorta, and a portex 17 gauge (3FG) polyethylene 
cannula, outer diameter 0.75mm, filled to the tip with 
heparin (1000 units/ml) was inserted into the right renal 
artery and the ligature was tied, thus securing the 
cannula in the renal artery. A total of 200 units of 
heparin (1000 units/ml) was injected into the renal artery 
and then oxygenated Tyrode solution was allowed to perfuse 
through the right renal artery and kidney at the rate of 
lOml/min.
The right kidney was then removed from the rat by cutting 
off at the aorta, the renal vein, the ureters, the adrenal 
gland and the connective tissue around the kidney, and was 
placed in a 5ml water-jacketed organ bath maintained at 
37°C. The isolated kidney was perfused with oxygenated 
Tyrode at a constant rate of lOml/min. by means of a 
Watson Marlow peristaltic pump. The time that elapsed
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between ligating the aorta and the beginning of the Tyrode 
perfusion of the kidney was never more than 40 seconds.
The Tyrode solution was of the following composition 
(mM): -
Sodium Chloride, 137; Potassium Chloride, 2.7;
Calcium Chloride, 1.8; Magnesium Chloride, 1.0;
Sodium bicarbonate, 11.9; Sodium hydrogen phosphate, 0.4;
Glucose, 5.5; Ascorbic acid, 0,1
The perfusing solution was aerated with a mixture of 95% 
oxygen and 5% carbon dioxide before passing through a 
warming coil maintained at 38°C. Changes in perfusion 
pressure were measured at a point close to the cannula by 
means of a pressure transducer (Bell and Howell, type 4- 
422-0001) and recorded on a Devices (M2) recorder.
After allowing time for the basal perfusion pressure to 
stabilise, usually 15 minutes, the isolated perfused 
kidney was subjected to either periarterial nerve 
stimulation (PNS) or to a bolus of NA. PNS was 
delivered at 5 minute intervals via bipolar platinum 
electrodes placed around the renal artery. Supramaximal 
rectangular pulses, 1msec, 50V, were applied for 5 seconds 
at 3Hz by means of a Grass, model S44, stimulator. The 
neural basis of the pressor response mediated by 
stimulation of the arterial adrenergic nerve was confirmed 
by abolition of the response after perfusion with
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guanethidine (O.OlmM, n=3 animals for each group). 
Noradrenaline (0.1ml of 10“^M) was injected directly into 
the perfusate proximal to the arterial cannula at 5 minute 
intervals. Once stable responses to PNS and NA infusion 
had been demonstrated, perfusion with other drugs began. 
The method of perfusion of the drugs was similar to that 
described previously in Chapter 2 for the isolated 
mesenteric vasculature. Once again the second response 
was taken for all the responses elicited by the PNS and NA 
infusion; the exception being experiments involving 
cocaine.
PNS and NA response data after drug perfusion in the 
preparations are expressed as a percentage of the control 
pressor response in order to standardize the data.
Male and female Japanese Hypertensive (SH) rats (Okamoto 
and Aoki, 1963) and female New Zealand Hypertensive rats 
(NZH) (Phelan, E.L., 1968) were compared to age matched 
male and female Wistar rats (University of Bath strain) 
and female New Zealand Normotensive rats (NZN) (University 
of Bath strain), respectively. The animals used were 14- 
16 weeks old and were supplied by the University of Bath 
Animal House.
Systolic blood pressure was monitored in the conscious 
animal by the tail-cuff method using a programmed electro- 
sphygmomanometer PE-300 (Narco bio-instruments) coupled to 
a flat-bed recorder (CR-6505, J J instruments).
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3.2ii Statistical Analysis
Results were analysed using Student*s t-test for group and 
paired mean comparisons. Probability levels equal to or 
less than 0.05 were taken as indicating statistically 




3.3i Table 3.1 summarises the systolic blood pressure, 
basal perfusion pressure and the pressor response to PNS 
and NA infusion in the six groups of rats.
It can be seen that in addition to having a significantly
higher blood pressure than the normotensive rats, the 
pressor responses to PNS and to NA infusion were also 
significantly greater in the SH and NZH preparations. The 
male rats generally had a higher basal perfusion pressure 
than the females (p<0.01 for the SH rats and p<0.001 for 
the Wistars). After the experiments described below 
(usually one hour), the weights of the kidneys were noted 
in order to ascertain the degree of oedema formation. As 
can be seen in Table 3.2, the degree of oedema formation
was kept to a minimum and its formation was essentially
the same in the preparations from all the animals used 
this study.
3.3ii Effect of isoprenaline on the pressor response to 
PNS and NA infusion
Isoprenaline alone had no significant effect on the basal 
perfusion pressure of the isolated kidney. In the 
preparations from the SH and NZH rats, isoprenaline 
(10-10M to 10"7M) caused a dose-dependant potentiation of 
the pressor response to PNS. At higher isoprenaline
70
Table 3.1
Systolic blood pressure and basal perfusion pressuref 
pressor responses to PNS and NA Infusion In kidnevs 
from male and female SH (SHR and SHR . respectively^ 
male and female Wlstar (W and W . respectively) and 









(3Hz, 50v, 1msec 
for 5 sec (mm Hg)
NA
Infusion 
(0.1 of 10 M) 
(mm Hg)
SHRm •191 + 4.5 
(20)






18.5 + 0.8 
(10)
Wm 95 + 5 (20)
189 + 4.0 
(20)
3.7.75 + 1.0 
(10)
9.4 + 0.5 
(10)
SHR - f •183 ± 5 
(20)
150 + 7.3 
(20)
+





9 6 + 4
(20)
155 + 7.5 
(20)
16.25 + 1.2 
(10)
10.9 + 0.8 
(10)
NZH •





22 + 2.1 
(10)
*
18.3 + 0.7 
(10)'
NZN 94.2 + 4 
(20)




9.2 + 0.6 
(10)
Values are given as mean + s.e of the mean.
Number in parenthesis = number of animals
. indicates significant differences between SH, NZH rats and respective 
control rats (p<0.01)
+ indicates significant differences between SH, NZH rats and respective 
control rats (p<0.05)
Basal perfusion pressure significantly greater in male rats than 
in female rats (p<0.01)




Wet weight of kidneys and oedema formation in the 
kidneys of male and female SH and Wistar rats 
(SH , SH , W and W respectively) and female NZH 
and NZN ratsm
% change in 
wet weight
Wet weight Cg) of 
kidney before 
start of experiment
SHRm 105 +.1.0 1.32 + 0.02
Wm 107 +1.1 1.32 + 0.03
SHRf 105 +0.9 1.23 + 0.02
wf 105 +0.7 1.22 + 0.01
NZH 105 +0.4 1.25 +0.02
NZN 106 + 0.8 1.24 + 0.02
Values are mean + s.e of mean 
n = 10 kidney for each group
Wet weight of kidney significantly greater in males 
than in females (p<0.01)
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concentrations, around 10“^M, no potentiation of the PNS 
pressor response was observed. Figs 3.1 a,b,c.
At lower isoprenaline concentration (10“H m to 10“^M) a 
smaller potentiation of the PNS pressor response was 
observed whereas the higher isoprenaline concentration 
(10“7m t0 10“6m ) caused an inhibition of the 
vasoconstrictor response to PNS in the preparations from 
the normotensive animals.
A typical trace of the potentiating effect of isoprenaline 
on the PNS response in the preparation from the SH rat is 
shown in Fig 3.2
Significant differences in the degree of potentiation were 
observed between the hypertensive and respective 
normotensive animals at each concentration of the 
isoprenaline.
As can be seen from Figs 3.3 a,b,c isoprenaline caused a 
dose dependant inhibition of the pressor response to NA 
infusion in the preparations from both, the hypertensive 
and the normotensive animals. There was no significant 
difference in the degree of inhibition between the 
preparations from the hypertensive and respective 
normotensive rats.
In order to investigate the effects of J3-adrenoreceptor 






























-710 "  10 "  10 ~  10
Isoprenaline concentration (M)
10-6
Fig 3.1a Effect of isoprenaline on the pressor response to 
PNS in the isolated perfused kidneys from male SH
(•---#) and male Wistar (•--*) rats.
Vertical lines indicate s.e. of mean.n - 4 animals 
for each group
At all points, SH response significantly greater 
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-10 -9 -8 -7 -610 10 10 10 10
Isoprenaline concentration (M)
Fig 3.lb Effect of Isoprenaline on the pressor response to 
PNS in the isolated perfused kidneys from female
SH (•___*) and female Wistar (*— _«) rats.
Vertical lines indicate s.e. of mean, n = 6 animals 
for SH rats, n = 4 animals for Wistar 
At all points, SH rat responses significantly greater 
























10-11 10-10 10-9 10-8 10-7
Isoprenaline concnetratlon (M)
Fig 3.1c Effect of Isoprenaline on the pressor response
to PNS in the Isolated perfused kidneys of female NZH
(•---•) and female NZN (*___#) rats.
Vertical lines indicate s.e. of mean, n = 5 animals 
for NZH rats, n = 4 animals for NZN rats.





Fig 3.2. Typical trace of the facilitatory effect of isoprenaline (Iso) on the pressor response to 






























Fig 3.3a. Effect of Isoprenaline on the pressor response to NA 
Infusion in the isolated perfused kidneys of male SH
(•---•) and male Wistar (•___•) rats.
Vertical lines indicate s.e. of mean (most omitted 
for clarity). n =^3 animals for each group 
Responses from 10 Mto 10 M isoprenaline significantly 
























-9 10-8 10 10-6
Isoprenaline concentration (M)
Fig 3.3b Effect of isoprenaline on the pressor response to 
NA infusion in the isolated perfused kidneys of
female SH (#-- •) and female Wistar (m ♦) rats.
Vertical lines indicate s.e. of mean (most omitted 
for clarity), n =g3 animals for each group.
Responses from 10 'flto 10 ~M isoprenaline concentrations 
significantly different from control Tyrode response 
(p<0.05) for femalg SH rat.g
Responses from 10 M to 10 M isoprenaline concentrations 
significantly different from control Tyrode response 
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-11 -10 -9 -8 -710 10 10 10 10
Isoprenaline concentration (M)
Fig 3.3c. Effect of isoprenaline on the pressor response to NA 
infusion in the isolated perfused kidneys of female
NZH (•---•) and female NZN (♦ -— «) rats.
Vertical lines indicate s.e. of mean (most omitted 
for clarity).
n = 3 animals for £gch group^
Responses from 10 M to 10 M isoprenaline concentrations 
significantly different from control Tyrode response 
(p<0.05) for both groups.
80
standard concentration of isoprenaline was chosen. The
standard concentration used was 10“^M in the females and 
10“8m in the males as these concentrations caused the 
greatest potentiation of the PNS pressor response in the 
control animals (Wistars and NZN).
3.3iii Effect of non-selective ft-adrenoreceptor 
antagonist on the isoprenaline induced 
effects on the pressor responses to PNS 
and NA infusion
Propranolol (5xlO“^M) was used as the non-selective £- 
adrenoreceptor antagonist. At the concentration employed 
in this study propranolol alone had no significant effect 
on the basal perfusion pressure or the PNS pressor 
response, but it significantly inhibited the isoprenaline 
induced potentiation of the pressor response to PNS in all 
the preparations. Fig 3.4.
Propranolol alone tended to cause a moderate enhancement 
of the pressor response to NA infusion in the preparation 
from the male SH rat only. The inhibitory effect of 
isoprenaline on the pressor response to NA infusion was 
reversed significantly by propranolol in the preparations 























150 Prop Iso + Prop
Fig 3.4. Effect of Prop(propranolol) on the isoprenaline (ISO)- 
induced facilitation of the pressor response to PNS of 
the isolated perfused kidneys of the SH, Wistar, NZH 
and NZN rats.
Male SH rat □  Female SH rat E3 Female NZH rat
Male Wistar rat |^ /| Female Wistar rat Female NZN rat
Vertical lines indicate s.e. of mean, 
n = 4 animals for each group.
All groups in Iso section significantly different 
from control response and all other sections (p(0.05)




















Iso Prop Iso + Prop
Fig 3.5 Effect of Prop (propranolol) on the Iso (isoprenaline)- 
Induced inhibition of the pressor response to 
exogenous NA in the isolated kidney of SH,Wistar, NZH 
and NZN rats.
Male SH rat p - ■ | Female SH rat j— ■ |
Male Wistar rat IZI Female Wistar rat s Female NZN rat
Vertical lines Indicate s.e. of mean 
n - 3 animals for each group.
All groups in Iso section significantly different 
from control response (p(0.05)
+ p<0.05 compared to control response
Female NZH rat
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3.3iv Effect of selective adrenoreceptor antagonist 
on the isoprenaline induced effects on the pressor 
respones to PNS and NA infusion
Atenolol (10"7m ) was used as the selective 
adrenoreceptor antagonist. At the concentration employed 
in this study, atenolol had no significant effect on the 
basal perfusion pressure or the pressor response to PNS in 
any of the preparations. Atenolol did not inhibit the 
isoprenaline induced potentiation of the pressor response 
to PNS in any of the preparations from any of the animals. 
Fig 3.6.
Atenolol (10“^M) alone tended to enhance significantly the 
pressor response to NA infusion in the preparations from 
male SH animals only (approximately 16% of control). This 
enhancement was not observed in any of the preparations 
from any of the other animals. In all the preparations, 
the atenolol reversed significantly the isoprenaline 





























Effect of atenolol on the isoprenaline induced 
potentiation of the pressor response to PNS in 
the isolated perfused kidney of SH, Wistar, NZH 
and NZN rats.
Male SH rat □  Female SH rat | | Female NZH rat
Male Wistar rat 12  Female Wistar rat Female NZN rat
Vertical lines indicate s.e. of mean, 
n = 3 animals for each male group, n ~ 4 animals for 
each female group.
All groups in Isoprenaline section and Isoprenaline 
+ atenolol section p<0.05, compared to control response. 






















Isoprenaline Atenolol Isoprenaline + 
atenolol
Fig 3.7. Effect of atenolol on the isoprenaline-induced 
inhibition of the pressor response to exogenous 
NA in the isolated perfused kidneys of SH, Wistar 
NZH and NZN rats.
Male SH rats n  Female SH rats Q  Female NZH rats
Male Wistar rats£3 Female Wistar ratsh^J Female NZN rats H
Vertical lines indicate s.e. of mean, n = 3 animals for 
each group.
All groups in isoprenaline section, p<0.05, compared to 
control response and all other sections.
+ p(0.05 compared to control response.
86
3.3v Effect of selective fi^-adrenoreceptor 
antagonist on the isoprenaline induced 
effects on the pressor responses to PNS 
and NA infusion
ICI 118,551 (5x10-7m) was used as the selective $2"
adrenoreceptor antagonist. At the concentration employed 
in this study, ICI 118,551 had no significant effect on 
the basal perfusion pressure or the pressor responses to 
PNS in any of the preparations. ICI 118,551 however, 
inhibited significantly the isoprenaline induced 
potentiation of the pressor response to PNS in the 
preparations from all the animals. Fig 3.8.
ICI 118,551 (5x 10-7m ) also reversed significantly the
isoprenaline induced inhibition of the pressor response to 
NA infusion in the preparations from all the animals. Fig 
3.9.
3.3vi Effect of angiotensin II on the pressor 
response to PNS and NA infusion
Angiotensin II (1 ng/ml) was found to cause a transient 
elevation of the basal perfusion pressure by around 20% 
when it was first perfused in the preparations. This 
elevation usually lasted for around 90 seconds before the 
perfusion pressure gradually returned to its pre­
angiotensin II perfusion levels. Further perfusion of 






















Isoprenaline ICI 118,551 Isoprenaline + 
ICI 118,551
Fig 3.8. Effect of ICI 118,551 on the isoprenallne-induced 
potentiation of the pressor response to PNS in the 










Vertical lines indicate s.e. of mean, n - 3 animals for 
each male group and n = 4 animals for each female group. 
+ p<0.05, * p<0.01 compared to control response.




















Isoprenaline ICI 118,551 Isoprenaline + 
ICI 118,551
Fig 3.9 Effect of ICI 118,551 on the isoprenaline-induced 
inhibition of the pressor response to exogenous NA 
in the isolated perfused kidneys of SH, Wistar 
NZH and NZN rats.
Male SH rats Q  Female SH rats |IIJ Female NZH rats g
Male Wistar rats Female Wistar rats^\[ Female NZN rats^jj
Vertical lines indicate s.e. of mean n = 3 animals for 
each group.
All groups in isoprenaline section, p(0.05, compared to 
other groups.
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discernable effect on the basal perfusion pressure. 
Angiotensin II significantly potentiated the pressor 
response to both PNS aVid NA infusions in all the 
preparations. Fig 3.10. The potentiating effect of 
angiotensin II on the PNS pressor response was found to be 
significantly greater in the preparations from SH and NZH 
animals than that in their respective controls.
The degree of the potentiating action of angiotensin II on 
the pressor response to NA infusion was found to be 
generally similar in all the preparations. Fig 3.11.
In the preparations from the normotensive animals, the 
degree of potentiation of the pressor response to PNS was 
similar to that of NA infusion; however in the 
preparations from the hypertensive animals the degree of 
potentiation of the pressor response to PNS was 
significantly greater than that of NA infusion.
The angiotensin II receptor antagonist, [Sarl-lle8] 
angiotensin II (Sar, 200 ng/ml), which itself did not 
significantly affect the basal perfusion pressure or the 
pressor response to PNS and NA infusion, completely 
prevented the potentiation of the pressor response to PNS 
and NA infusion induced by the angiotensin II. Table 3.3
The effect of cocaine (500 ng/ml) on the pressor response 
to PNS and NA infusion is shown in Fig 3.12. and 3.13. The 
concentration of cocaine employed in this study did not 


















All Sar All + Sar
Fig 3.10 _ _
I 1 8 IEffect of angiotensin II (All) and |_Sar -lie angiotensin II 
(Sar) on the pressor response to PNS in isolated perfused 
kidneys from SHf Wistar, NZH and NZN rats.
Male SH rats | | Female SH rats Female NZH rats
Male Wistar rats [71 Female Wistar rats Female NZN rats
Vertical lines indicate s.e. of mean, n - 4 animals 
for each group.
* p<0.01, Q p<0.001 compared to control response and other sections 






















All Sar All + Sar
Fig 3.11. Effect of angiotensin II (All) and [sar -Ile^] 
angiotensin II (Sar) on the pressor response 
to exogenous NA in the isolated perfused kidneys 
from SH, Wistar, NZH and NZN rats.
Male SH rats | j Female SH rats P^jFemale NZH rats ^
Male Wistar rats \/\ Female Wistar rats[\] Female NZN rats^j
Vertical lines indicate s.e. of mean, n = 3 animals 
for each group.
+ p<0.05, * p<0.01 compared to control response 




























All Cocaine All + Cocaine
Fig 3.12 Effect of cocaine on the angiotensin II (All)- induced
potentiation of the pressor response to PNS in the isolated 
perfused kidneys from SH, Wistar, NZH and NZN rats.
Male SH rats | [ Female SH rats -j— | Female NZH rats
Male Wistar rats[/{ Female Wistar rats[\| Female NZN rats£Q|
Vertical lines indicate s.e. of mean, n = 4 animals for 
each group.
All sections, hypertensive animals compared to respective 
normotensive animals, p<0.01 
+ p<0.05 compared to cocaine section 






















All Cocaine Cocaine + All
Fig 3.13.
Effect of cocaine and angiotensin II (All) on the pressor 
response to exogenous NA in the isolated perfused kidneys 
of SH, Wistar, NZH and NZN rats.
Male SH rats | j Female SH rats |— } Female NZH rats
Male Wistar rats \Z\ Female Wistar rats |^] Female NZN rats H
Vertical lines indicate s.e. of mean, n - 3 animals for 
each group.
All sections, except for All section, hypertensive animals 
compared to respective normotensive animals, p<p.05 
+ p(0.05 compared to cocaine section 
. p^0.05 compared to All section
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be seen from Fig 3.12 and 3.13, cocaine significantly 
potentiated the pressor responses to PNS and NA infusions 
in all the preparations. The degree of the potentiation 
of the PNS pressor response was found to be significantly 
higher than the degree of potentiation of the NA infusion 
pressor response in all the preparations. The degree of 
potentiation of the pressor response to PNS and NA 
infusion was found to be greater in the preparations from 
the hypertensive animals than that in the respective 
normotensive animals.
When angiotensin II (1 ng/ml) was simultaneously perfused 
with the cocaine (500 ng/ml), the potentiation of the 
pressor response to both PNS and NA infusion was further 
augmented and the effect appeared to be additive.
The facilitatory effect of angiotensin II on the PNS 
pressor response was greater in the SH and NZH 
preparations than in the Wistars and NZN preparations in 
the presence of cocaine, as well as in its absence. Fig 
3.12.
Thus far the results indicate that in the preparations 
from male and female animals the vasoconstrictor responses 
to PNS are potentiated by £ - adrenoreceptor stimulation 
and by activation of angiotensin II receptors and that 
this potentiation is greater in the preparations from SH 
and NZH animals than that in the Wistars and NZN animals.
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The next series of experiments explore the relationship 
between the p - adrenoreceptors and the angiotensin II 
receptors.
3.3vii Effect of angiotensin converting
enzyme inhibitor on the isoprenaline 
induced effects on the pressor responses 
to PNS and NA infusion
Captopril (5xlO”^M) was used as the angiotensin converting 
enzyme inhibitor in this experiment. At this
concentration the captopril had no significant effect on 
the basal perfusion pressure or the pressor responses to 
PNS and NA infusion. Captopril, however, effectively 
inhibited the isoprenaline induced potentiation of the 
pressor response to PNS in all the preparations, whilst 
not having any significant effect on the isoprenaline 
induced inhibition of the pressor response to NA infusion 
in any of the preparations. Figs 3.14 and 3.15.
3.3viii Effect of [Sar^-lle^]
angiotensin II (Sar) on the isoprenaline 
induced effects on the pressor responses 
to PNS and NA infusion
Sar (200 ng/ml) alone had no significant effect on the 
basal perfusion pressure or pressor responses to PNS and 
NA infusions. However, Sar effectively inhibited the 




































Isoprenaline Captopril Isoprenaline + 
Captopril
Fig 3.14 Effect of captopril on the isoprenaline-induced
potentiation of the pressor response to PNS in the 
isolated perfused kidneys of SH, Wistar, NZH and 
NZN rats.
Male SH rats | | Female SH rats {— | Female NZH rats
Male Wistar rats|/| Female Wistar ratsfs^ J Female NZN rats
Vertical lines indicate s.e. of mean, n = 3 animals for 
each group.










































Isoprenaline Captopril Isoprenaline + 
Captopril
Fig 3.15 Effect of captopril on the isoprenaline-induced
inhibition of the pressor response to exogenous NA 
in the isolated perfused kidney of SH, Wistar,
NZH and NZN rats.
Male SH rats QJ Female SH rats {-— | Female NZH rats
Male Wistar rats^J Female Wistar rats|\j Female NZN rats
Vertical lines indicate s.e. of mean, n = 3 animals 
for each group.
All groups in isoprenaline section and captopril + 
isoprenaline section significantly different from 
control response and captopril section p<0.05.
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to PNS in all the preparations, whilst not having any
significant effect on the isoprenaline induced inhibition 
of the pressor response to NA infusion in any of the
preparations. Figs 3.16 and 3.17.
3.3ix Effect of ICI 118,551 on the angiotensin II 
potentiation of the pressor response to PNS 
and NA infusion
As demonstrated earlier, ICI 118,551 (5x 10~7m ) alone had
no significant effect on the basal perfusion pressure or
pressor responses to PNS and NA infusion. From Fig 3.18 
and 3.19 it can be seen that ICI 118,551 had no 
significant effect on the angiotensin II potentiation of 



























isoprenaline Sar Isoprenaline + 
Sar
1 8"1Fig 3.16 Effect of [sar -I-e J angiotensin II (Sar) on the 
isoprenaline-induced potentiation of the pressor 
response to PNS in the isolated perfused kidneys 
of SH, Wistar, NZH and NZN rats
Male SH rats | | Female SH rats Female NZH rats
Male Wistar rats[/j Female Wistar ratsf\] Female NZN rats
Vertical lines indicate s.e. of mean, n = 3 animals 
for each group.






















Isoprenaline Sar Isoprenaline + 
Sar
« 1 Q n
Fig 3.17 Effect of [Sar -lie J angiotensin II (Sar) on the
isoprenaline-induced inhibition of the pressor response 
to exogenous NA in the isolated perfused kidneys from 
SH, Wistar, NZH and NZN rats
Male SH rats |^ j Female SH rats jZZJ Female NZH rats ^  
Male Wistar ratsf/7} Female Wistar ratsf\] Female NZN rats^
Vertical lines indicate s.e. of mean, n 3 animals 
for each group.
All groups in Isoprenaline section and isoprenaline + Sar 





























All ICI 118,551 All + ICI 118,551
Fig 3.18 Effect of ICI 118,551 on the angiotensin II <AII)- 
induced potentiation of the pressor response to PNS 
in isolated perfused kidneys from SH, Wistar, NZH 
and NZN rats.
Male SH rats Q  Female SH rats Q  Female NZH ratsj^
Male Wistar ratsj^j Female Wistar ratsj\[ Female NZN rats
Vertical lines indicate s.e. of mean, n = 3 animals for 
each group.























All ICI 118,551 All + ICI 118,551
Fig 3.19 Effect of ICI 118,551 on the angiotensin II (AII)- 
induced potentiation of the pressor response to 
exogenous NA in the isolated perfused kidneys of
SH, Wistar, NZH and NZN rats.
Male SH rats J^ J Female SH rats Female NZH rats ^
Male Wistar ratsj/^ j Female Wistar ratsjN^ Female NZN ratsj^
Vertical lines indicate s.e. of mean, n = 3 animals 
for each group.




The results described in this chapter suggest that 
physiological mechanisms facilitating sympathetic 
neurotransmission in the kidney are enhanced in the SH and 
NZH animals (hypertensive animals) compared to the Wistars 
and NZN (normotensive animals). This facilitation seems 
to be qualitatively and quantitatively similar in male and 
female SH rats and female NZH rats. That the facilitatory 
mechanisms are located presynaptically can be inferred
from the comparisons of the effects of isoprenaline and 
angiotensin II on the pressor responses to PNS and
infusion of exogenous NA.
The results also suggest that the uptake I mechanism seems
more sensitive to cocaine in the kidney than in the
mesenteric vasculature. The isolated kidney seemed to 
have an increased pressor response to PNS and NA infusion 
compared to the isolated mesenteric vasculature. This
could result from the tissue being more sensitive, possibly due
to increased number of postsynaptic receptors and/or increased 
facilitatory mechanisms.
However, it should be noted that the rate of perfusion in the
isolated perfused mesenteric vasculature was 5 ml/min and the
perfusion rate for the isolated kidney preparation was 10 ml/min.
This increased perfusion rate could affect the basal perfusion
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pressure and the difference in the perfusion rates could also, 








4.1i Goldblatt, two—kidney, one-clip hypertension
Silver clips were made from silver tape by bending double 
a 5 mm x 2 mm x 0.2 mm thick piece of the tape over 
another to give a clip with an internal diameter of 0.2 mm 
(silver tape supplied by Johnson Mathey & Co. Ltd).
Fig 4.1.
Male and female Wistar rats, aged four to five weeks, were 
anaesthetised with a mixture of Hypnorm (each millilitre 
containing 0.315 mg fentanyl citrate and 10 mg 
fluanisone), water and Hypnovel (each millilitre 
containing 5 mg of midazolam) in the proportion,
Hypnorm: Water for injection : Hypnovel (midazolam
5 mg/ml)
1 volume : 2 volumes : 1 volume
An intraperitoneal injection of 0.3 ml/lOOg body weight of 
the above mixture was used.
A small patch of fur was shaved off on the side of the 
animal above the right kidney. A small incision was made
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to expose the kidney and the major renal blood vessels. 
The renal artery was gently separated from the renal vein 
and a silver clip (internal diameter, 0.2 mm) was put 
around the renal artery in order to occlude the artery. 
The animals were then sutured up with Michel clips and 
left in a warm cage to gain consciousness, which usually 
occurred twenty to thirty minutes after the surgery.
In the sham operated animals a small incision on the side 
of the animal above the right kidney was made and the 
kidney exposed. The incision was then sutured up using 
Michel clips and the animals were transferred to a warm 
cage to regain consciousness.
Once the animals had regained consciousness they were left 
in the cages for one to two weeks before being handled.
For clarity,
Goldblatt, two kidney-one clip rats are referred to as 
renal hypertensive rats, WmR and WfR refer to male and 
female animals respectively.
Sham operated animals are referred to as control Wistar 




4.1ii Blood pressure measurements
Systolic blood pressure was monitored in the rats when the 
animals had recovered from the operation, usually one to 
two weeks after the surgery (i.e. seven weeks old). 
Systolic blood pressure was monitored in the conscious 
animals by the tail-cuff method using a programmed 
electro-sphygmomanometer PE-300 (Narco bio-instruments) 
coupled to a flat-bed recorder (CR-6505, J.J. 
instruments). The systolic blood pressure was measured 
weekly; the average of three measurements was taken as the 
mean systolic blood pressure.
4.1iii Chronic ICI 118,551 treatment
At the age of seven weeks, some of the male and female 
renal hypertensive rats were randomly chosen for chronic 
treatment with ICI 118,551 and set aside in separate 
cages.
Chronic treatment with ICI 118,551 was started when the 
animals were eight weeks old and was carried on until they 
were between twelve and thirteen weeks old, when they were 
sacrificed. Chronic treatment with ICI 118,551 consisted 




Goldblatt, two-kidney^one - clip rats chronically treated 
with ICI 118,551 are referred to as renal hypertensive 
rats chronically treated with ICI 118,551, WmRI and WfRI 
refer to male and female animals respectively.
4.1iv Isolated mesenteric vascular bed 
preparation
The animals were sacrificed at twelve weeks of age and the 
isolated perfused mesenteric vasculature was set up as 
previously described in Section 2.2i. The preparation was 
placed in a 5 ml water-jacketed organ bath maintained at 
37°C and perfused with a modified Kreb's solution 
(composition as described in Section 2.2i) at a constant 
flow rate of 5 ml/min by means of a Watson Marlow 
peristaltic pump.
The perfusing solution was aerated with a mixture of 95% 
oxygen and 5% carbon dioxide before passing through a 
warming coil maintained at 38°C. Changes in perfusion 
pressure were measured at a point close to the cannula by 
means of a pressure transducer (Bell and Howell, type 4- 
422-0001) and recorded on a Devices (M2) recorder.
After allowing time for the basal perfusion pressure to 
stabilize, usually 15 minutes, the isolated perfused 
mesenteric vasculature was subjected to either PNS or to
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a bolus of NA. PNS was delivered at 5 minute intervals 
via bipolar platinum electrodes placed around the superior 
mesenteric artery. Supramaximal rectangular pulses, 1 
msec, 80V were applied for 10 sec. at 30Hz by means of a 
Grass, model S44, stimulator. The neural basis of the 
pressor response mediated by stimulation of the arterial 
adrenergic nerve was confirmed in the preparations from 
all the groups by abolition of the response after 
perfusion with guanethidine (O.OlmM, n=3 animals for each 
group). NA was injected directly into the perfusate 
proximal to the arterial cannula at 5 minute intervals in 
a volume of 0.1 ml. of a 10“^M solution.
Once stable responses to PNS and NA infusion had been
demonstrated, perfusion with other drugs began. The 
method of perfusion of the drugs was as described
previously in Section 2.2i.
Data was derived from the second response to PNS or NA 
infusion; the exception being experiments involving 
cocaine, when the first response was taken.
PNS and NA response data after drug perfusion in the 
preparations are expressed as a percentage of the control 
pressor response in order to standardize the data.
Age matched male and female Wistar rats (University of 
Bath strain) were used in this study. The animals used
were supplied by the University of Bath Animal House.
Ill
4.1v Statistical Analysis
Results were analysed using Student*s t-test for group and 
paired mean comparisons. Probability levels equal to or 
less than 0.05 were taken as indicating statistically 




4.2i Progression of the Hypertension in the _
Goldblatt, two- kidney one-clip hypertensive rat
The degree of hypertension induced by the two-kidney,one - 
clip procedure and the effect of chronic treatment with 
ICI 118,551 (25 mg/kg, p.o., daily) on this hypertension 
is illustrated in Figs 4.2 and 4.3 for the male and female 
rats respectively.
Chronic treatment with ICI 118,551 attenuated the degree 
of hypertension in the renal hypertensive animals though 
it did not altogether stop the progression of the 
hypertension.
There were no significant differences observed in the 
progression of the hypertension, or the effect of chronic 
treatment with ICI 118,551 on this hypertension, between 
the males and the females.
Table 4.1. shows the pressor responses to PNS and NA 
infusion in the isolated mesenteric vasculature of all the 
groups of rats.
As can be seen from Table 4.1, the pressor responses to 
PNS and NA infusion were significantly greater in the 
preparations from the renal hypertensive animals than in 































Comparison of systolic blood pressure in male rats.
Point "x" indicates age when chronic treatment of two-kidney, 
one-clip renal hypertensive rats with ICI 118,551 was begun.
Vertical lines indicate s.e. of mean, n = number or rats in 
each group.
 *-- •, n=9; two-kidney, one-clip renal hypertensive rats
 *-- •, n=4; sham-operated rats
0-- Q t n=6; renal hypertensive rats treated chronically with ICI 118,551
+ p<0.05, significantly different from the other two groups
* p^0.05, significantly different from untreated renal 
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Comparison of systolic blood pressure in female rats.
Point "x" indicates age when chronic treatment of two-kidney, 
one-clip renal hypertensive rats with ICI 118,551 was begun. 
Vertical lines indicate s.e. of mean, n = number of rats in 
each group.
 •-- ., n=9; two-kidney, one-clip renal hypertensive rats
 #-- m, n=4; sham-operated rats .
0-- Q, n=6; two-kidney, one-clip renal hypertensive rats
treated chronically with ICI 118,551.
+ p<0.05, significantly different to other two groups.
* p<.0.05, significantly different from untreated renal 
hypertensive rats from age 9 weeks.
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Table 4.1
Pressor responses to PNS and NA Infusion In the Isolated 
mesenteric vasculatures of male and female renal hypertensive 
rats, male and female renal hypertensive rats treated 
chronically with ICI 118,551 and sham-operated male & female 
Wistar rats
Pressor response 
&  mm Hg
PNS (30Hz,80v,lOsec) NA infusion 
(0.1ml of 10 M solution)
Male renal hypertensive + 9.5 + 0.5 12.5 + 0.5
(21) (12)
Male renal hypertensive 8.2 + 0.2 12.6 + 1.1
+ ICI 118,551 (12) (6)
Male Wistar rat, sham . 6.9 + 0.4 . 9.5 + 0.5
operated (20) (10)
Female renal hypertensive + 9.8 + 0.2 12.5 + 0.5
(21) (12)
Female renal hypertensive 8.5 + 0.3 13.5 + 0.7
+ ICI 118,551 (12) (6)
Female Wistar rat, sham . 6.5 + 0.7 .10.3 + 0.5
operated (20) (10)
Values given are mean + s.e. of mean
Number in parenthesis, number of observations
+ p(0.05; significant differences between renal hypertensive
rats and all other groups.
. p(0.05; significant differences between sham operated animals 
and all other groups.
116
that the pressor response to PNS in the preparation from 
the renal hypertensive rat was also greater than that from 
the animals chronically treated with ICI 118,551.
Basal perfusion pressure was slightly, but significantly 
elevated in the preparations from the renal hypertensive 
animals. Table 4.2.
4.2ii Effect of isoprenaline on the pressor responses to 
PNS and NA infusion in the preparations from renal 
hypertensive rats, renal hypertensive rats treated 
chronically with ICI 118,551 and Wistar rats
At the concentrations employed in this study (10“^M to 
10“6m ), isoprenaline alone had no significant effect on 
the basal perfusion pressure of the isolated mesenteric 
vascular preparation from any of the groups. In the 
preparations from the untreated renal hypertensive and 
control animals, isoprenaline caused a dose dependent 
potentiation of the pressor response to PNS at the lower 
isoprenaline concentrations (10“^M to 5x 10~8m ). However, 
the degree of the isoprenaline-induced potentiation of the 
pressor response to PNS in the untreated renal 
hypertensive animals was significantly greater than that 
in the control animals at all concentrations of 
isoprenaline except for 5x10“^^ in the female 
preparations. At higher isoprenaline concentrations 
(>5x 10~8m ) inhibition of the vasoconstrictor response to 
PNS was observed in the normotensive Wistar rats.
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Table 4.2
Basal perfusion pressure of isolated perfused mesenteric 
vasculatures of male and female renal hypertensive rats, 
male and female renal hypertensive rats treated 
chronically with ICI 118,551 and sham operated Wistar 
rats.
Basal perfusion pressure 
(mm Hg)
Male renal hypertensive 41.5 + 
(10)
2.3





Male Wistar rat, sham 
operated
. 33.3 + 
(10)
2.9
Female renal hypertensive 40.3 + 
(10)
1.3





Female Wistar rat, sham 
operated
. 31.6 + 
(10)
3.4
Values are mean + s.e. of mean
Number in parenthesis, number of animals
. p<0.05; significant difference between sham operated
animals and all other groups
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Isoprenaline did not have any effect on the pressor 
response to PNS in the renal hypertensive animals treated 
chronically with ICI 118,551. Fig 4.4 a,b for 
preparations from male and female rats respectively.
As can be seen from Fig 4.5 a,b, for preparations from 
male and female rats respectively, isoprenaline caused a 
dose dependent inhibition of the pressor response to NA 
infusion in the preparations from untreated renal 
hypertensive animals, renal hypertensive animals 
chronically treated with ICI 118,551 and normotensive* 
Wistar rats.
There was no significant difference in the degree of 
isoprenaline-induced inhibition of the pressor response to 
NA infusion in any of the preparations.
In order to investigate the effects of £-adrenoreceptor 
antagonists, a standard concentration of 10“8m 
isoprenaline was chosen.
4.2iii Effect of atenolol on the isoprenaline-induced
effects on the pressor responses to PNS and NA
infusion in the preparations from untreated renal
%
hypertensive rats and Wistar rats
Atenolol (10~7m ) was employed as the selective 
adrenoreceptor antagonist. At this concentration atenolol 
































Effect of isoprenaline on the pressor response to PNS in the 
isolated perfused mesenteric vasculatures of two-kidney,
one-clip renal hypertensive male rats (WmR, .-- n=3),
sham-operated male rats (Wm, •-- «, n=4) and the renal hypertensive
male rats chronically treated with ICI 118,551 (WmRI, 0--0 , n=3)
Vertical lines indicate s.e. of mean, n = number of animals in 
each group.
WmR compared to Wm p<0.05
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Effect of isoprenaline on the pressor response to PNS in the 
isolated perfused mesenteric vasculatures of two-kidney,
one-clip renal hypertensive female rats (WfR, .----- n=3)
sham-operated female rats (Wf, • • , n-4) and the renal
hypertensive female rats chronically treated with ICI 118,551 
(WfRI, q 0 , n=3).
Vertical lines indicate s.e. of mean, n = number of animals 
in each group.
WfR comparedgto Wf, p(0.05 for all isoprenaline concentrations 
except 5x10 M



























Effect of Isoprenaline on the pressor response to exogenous NA 
In the Isolated perfused mesenteric vasculatures of two-kidney,
one-clip renal hypertensive male rats (.-- ., n=3) , sham-operated
male rats n=4) and the renal hypertensive male rats
treated chronically with ICI 118,551 (q  £>, n=3)
Vertical lines indicate s.e. of mean (most omitted for clarity) 
n = number of animals for each group.





























Effect of Isoprenaline on the pressor response to exogenous NA 
in the isolated perfused mesenteric vasculatures of two-kidneys,
one-clip renal hypertensive female rats (.--., n=3) , sham-
operated female rats (*___., n-4) and the renal hypertensive female
rats treated chronically with ICI 118,551 (Q . ,.q , n=3)
Vertical lines indicate s.e. of mean (most omitted for clarity) 
n = number of animals for each group
+ p<0.05, all three groups compared to control pressor response
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pressure or the pressor response to PNS in any of the 
preparations. Atenolol did not inhibit the isoprenaline 
induced potentiation of the pressor response to PNS in any 
of the preparations. Fig 4.6
Atenolol however significantly reversed the isoprenaline 
induced inhibition of the pressor response to NA infusion 
in all the preparations. Fig 4.7
4.2iv Effect of ICI 118,551 on the isoprenaline-induced 
effects on the pressor responses to PNS and NA 
infusion in the preparations from untreated renal 
hypertensive rats and Wistar rats
ICI 118,551 (5x10-7m) was used as the selective £ 2 “
adrenoreceptor antagonist. At this concentration the 
antagonist had no significant effect on either the basal 
perfusion pressure or the pressor responses to PNS and NA 
infusions in any of the preparations. However, ICI 
118,551 completely inhibited the isoprenaline-induced 
potentiation of the PNS pressor response in preparations 
from both, the untreated renal hypertensive and 
normotensive Wistar rats. Fig 4.8.
ICI 118,551 significantly reversed the isoprenaline 
induced inhibition of the pressor response to NA infusion 


























Effect of atenolol on the isoprenaline-induced potentiation of 
the pressor response to PNS in the isolated perfused mesenteric 
vasculatures of male and female two-kidney, one-clip renal 
hypertensive rats (W R and WfR respectively) and male and female 
sham operated rats (W and W , respectively).
Vertical lines indicate s.e. of mean n = 3 animals for all groups
V  □  "» 0
WfR 0  Wf 0
+ p<0.05 compared to control pressor response
. p<0.01 compared to control pressor response





















Isoprenaline Atenolol Isoprenaline + 
atenolol
Fig 4.7
Effect of atenolol on the isoprenaline induced inhibition of 
the pressor response to exogenous NA in the isolated perfused 
mesenteric vasculatures of male and female two-kidney, one- 
clip renal hypertensive rats (WmR and WfR, respectively) and 
male and female sham-operated rats (Wm and Wf, respectively). 
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group.
V  Q  Wm 0
wfR E3 wf S
-fp<0.05, all groups in this section significantly different 



























Effect of ICI 118,551 on the isoprenaline induced potentiation 
of the pressor response to PNS in the isolated perfused mesenteric 
vasculatures of male and female two-kidney, one-clip renal
hypertensive rats (WmR and WfR, respectively) and male and female
sham-operated rats (Wm and Wf, respectively).
Vertical lines indicate s.e. of mean, n = 3 animals for all groups.
% R  0  Wm 0
WfR 0  Wf 0
+ p^0.05; significantly different compared to control pressor 
response
. p(0.01; significantly different compared to control pressor 
response

























Effect of ICI 118,551 on the Isoprenaline-induced inhibition of 
the pressor response to exogenous NA in the isolated perfused 
mesenteric vasculatures of male and female two-kidney, one-clip 
renal hypertensive rats (WmR, WfR, respectively) and male and 
female sham-operated rats (Wm, Wf, respectively).




“j“ p<0.05; all groups in this section significantly different 
to those in all other sections.
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4.2v Effect of ICI 118,551 and atenolol on the
isoprenaline induced inhibition of the pressor 
response to NA infusion in the renal hypertensive 
rats treated chronically vith ICI 118,551
Fig 4.10 illustrates the effect of ICI 118,551 and 
atenolol on the isoprenaline induced inhibition of the 
pressor response to NA infusion in preparations from renal 
hypertensive animals chronically treated with ICI 118,551. 
Atenolol and ICI 118,551 significantly reversed the 
isoprenaline induced inhibition of the NA pressor 
response.
4.2vi Effect of angiotensin II (All) and cocaine on the 
pressor response to PNS and NA infusion in the 
preparations from untreated rats, renal 
hypertensive rats, renal hypertensive rats treated 
chronically with ICI 118,551 and normotensive 
Wistar rats
Angiotensin II (10 ng/ml) had no significant effect on the 
basal perfusion pressure of any of the preparations. 
Angiotensin II significantly potentiated the pressor 
response to PNS in all the preparations. The degree of 
this potentiation was greatest in the preparations from 
the untreated renal hypertensive animal followed by 
preparations from the ICI 118,551 treated animals and 
control animals. Preparations from renal hypertensive 






















Effect of atenolol (aten) and ICI 118,551 (ICI) on the 
isoprenaline (Iso)-induced inhibition of the pressor response 
to exogenous NA in the isolated perfused mesenteric vasculatures 
of male and female two-kidney, one-clip renal hypertensive rats 
chronically treated with ICI 118,551 (WmRI, WfRI, respectively). 
Vertical lines indicate s.e. of mean, n - 3 animals for each 
group
WfRI ^V 1 *
“H p <o .05; all groups in this section significantly different 
to those in all other sections.
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renal hypertensive animals exhibited a significantly 
greater angiotensin II-induced potentiation of the pressor 
response to PNS than that from the control normotensive 
Wistars. Fig 4,11.
The degree of the angiotensin II induced potentiation of 
the pressor response to NA infusion in the preparations 
from the renal hypertensive rats treated chronically with 
ICI 118,551 and untreated renal hypertensive animals was 
significantly greater (p<0.05) than that in the 
preparations from the control Wistar animals. Fig 4.12.
Only in the preparations from the renal hypertensive 
animals treated chronically with ICI 118,551 and untreated 
renal hypertensive animals was the degree of angiotensin 
II-induced potentiation of the PNS pressor response 
significantly greater than that of the NA infusion 
(p<0.05)•
The specific angiotensin II receptor antagonist, Sar.
(200 ng/ml), which alone did not significantly affect the 
basal perfusion pressure or the pressor response to PNS 
and NA infusion, completely abolished the angiotensin II- 
induced potentiation of the pressor response to PNS and NA infusion 
in all the preparations. Figs 4.11 and 4.12.
The effects of cocaine (5 ug/ml), which alone had no 
significant effect on the basal perfusion pressure, on the 























All Sar All + Sar
Fig 4..11
Effect angiotensin II (All) and |_Sar*-Ile® J angiotensin II (Sar) 
on the pressor response to PNS in the isolated perfused mesenteric 
vasculatures of male and female two-kidney, one-clip renal 
hypertensive rats (WmR, WfR respectively), male and female sham 
operated rats (Wm, Wf respectively) and male and female renal 
hypertensive rats chronically treated with ICI 118,551 
(WmRI, WfRI respectively).









+ p(0.05 compared to control pressor response
. p(0.01 compared to control pressor response
* p^0.05 compared to Wm & Wf























All Sar All + Sar
Fig 4.12
1 8Effect of angiotensin II (All) and Sar -lie angiotensin II (Sar) 
on the pressor response to exogenous NA in the isolated perfused 
mesenteric vasculatures of male and female two-kidney, one-clip 
renal hypertensive rats (WmR, WfR respectively), male and female 
sham-operated rats (Wm, Wf respectively) and male and female renal 
hypertensive rats chronically treated with ICI 118,551 (WmRI, WfRI 
respectively).





* p^0.05 compared to sham-operated rats
-J-p<0.05, groups in this section significantly different to control 
pressor response  ^ ~
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Figs 4.13 and 4.14. Cocaine significantly potentiated the 
pressor response to PNS and produced a moderate 
potentiation of the NA infusion pressor response in all 
the preparations. The degree of potentiation of the PNS 
pressor response in the preparations from the renal 
hypertensive rats was greater than that from the renal 
hypertensive rats treated chronically with ICI 118,551 
which in turn was greater than that from the normotensive 
Wistar rats.
No significant difference in the degree of potentiation of 
the pressor response to NA infusion between any of the 
preparations from any of the animals was observed.
When All (10 ng/ml) was administered together with cocaine 
(5 pg/ml), the potentiation of the pressor response to 
both PNS and NA infusion was potentiated further and 
appeared to be additive.
The facilitatory effect of All on the PNS pressor response 
was greatest in the preparations from the renal 
hypertensive animals followed by that in the renal 
hypertensive animals treated chronically with ICI 118,551 
and least in the preparations from the normotensive 




























Cocaine + All CocaineAll 
Fig 4.13
Effect of cocaine on the angiotensin II (All)-induced potentiation 
of the pressor response to PNS in the isolated perfused mesenteric 
vasculatures of male and female two-kidney, one-clip renal 
hypertensive rats (WmR, WfR respectively), male and female sham- 
operated rats (Wm, Wf respectively) and male and female renal 
hypertensive rats treated chronically with ICI 118,551 
(WjjjRI , WfRI respectively)
Vertical lines indicate s.e. of mean, n = 3 animals for each group
V  □  Wm 0  V* ■
W.pR B QW WfRI
* p(0.05 compared to sham-operated rats
. p(0.05 compared to renal hypertensive rats chronically treated 
with ICI 118,551





















All All + Cocaine Cocaine
Fig 4.14
Effect of cocaine on the angiotensin II (All)-induced potentiation 
of the pressor response to exogenous NA in the isolated perfused 
mesenteric vasculatures of male and female two-kidney, one-clip 
renal hypertensive rats (WmR, WfR respectively), male and female 
sham-operated rats (Wm , Wf) and male and female renal hypertensive 
rats treated chronically with ICI 118,551 (WmRI, WfRI respectively) 
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group
-|- p<0.05; groups in this section significantly different from 
those in cocaine section 
* p(0.05, compared to sham-operated rats
W R  □  wm 0  WRI ■m *— * m K— 1 m
WfR 0  wf S  WfRI
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4.2vii Effect of captopril on the isoprenaline induced 
effects on the pressor response to PNS and NA 
infusion
Captopril (5xlO“^M) alone had no significant effect on the 
basal perfusion pressure or the pressor response to PNS 
and NA infusion in any of the preparations. However
captopril effectively inhibited the isoprenaline induced 
potentiation of the pressor response to PNS in the 
preparations from the untreated renal hypertensive animals 
and normotensive animals whilst not having any significant 
effect on the isoprenaline induced inhibition of the 
pressor response to NA infusion in any of the 
preparations. Figs 4.15 and 4.16.
Effect of Sar on the isoprenaline induced 
effects on the pressor response to PNS and 
NA infusion
Sar (200 ng/ml) alone had no significant effect on the 
basal perfusion pressure or the pressor response to PNS 
and NA infusion in any of the preparations. Sar 
effectively inhibited the isoprenaline induced 
potentiation of the PNS pressor response in the 
preparations from untreated renal hypertensive rats and 
Wistar rats whilst not having any significant effect on 
the isoprenaline induced inhibition of the NA infusion 


























Effect of Captopril (Capt) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculatures of male and female two-kidney, 
one-clip renal hypertensive rats (WmR, W^R respectively and male ^ 
and female sham-operated rats,Wm, Wf respectively)
Vertical lines indicate s.e. of mean, n = 3 animals for each group
V  P  »m 0
WfR B 'l S
+ p<0.05, compared to control pressor response
p<0.ol, compared to control pressor response





















Iso + CaptIso Capt
Fig 4.16
Effect of captopril (Capt) on the isoprenaline (Iso)-induced 
inhibition of the pressor response to exogenous NA in the 
isolated perfused mesenteric vasculatures of male and female 
two-kidney, one-clip renal hypertensive rats (WmR, WfR respectively), 
and male and female sham-operated rats (Wm , Wf respectively).
Vertical lines indicate s.e. of mean, n = 3 animals for each group
V  □  ”m 0
fffR H  wf S
—f-p^0.05, groups in these sections significantly different to 






















Sar Iso + SarIso
Fig 4.17
I 1 8 IEffect of JjSar -lie J angiotensin II (Sar) on the isoprenaline 
(Iso)-induced potentiation of the pressor response to PNS in 
the isolated perfused mesenteric vasculatures of male and female 
two-kidney, one-clip renal hypertensive rats (WmR, WfR respectively) 
and male and female sham-operated rats (Wm, respectively). 
Vertical lines indicate s.e. of mean, n - 3 animals for each group
V  □  0
WfR 0  Wf S
+ p(0.05, compared to control pressor response 
. p<0.01, compared to control pressor response 





















Iso Sar Iso + Sar
Fig 4.18
Effect of [j3ar*-Ile^ angiotensin II (Sar) on the isoprenaline 
(Iso)-induced inhibition of the pressor response to exogenous NA 
in the isolated perfused mesenteric vasculatures of male and 
female two-kidney, one-clip renal hypertensive rats (WmR, W^R 
respectively) and male and female sham-operated rats 
(Wm, Wf respectively).
Vertical lines indicate s.e. of mean, n = 3 animals for each group
v □ v 0
WfR □  Wf S
-|-p(0.05, groups in these sections significantly different 
to those in Sar section
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Effect of ICI 118,551 on the angiotensin II 
potentiation of the pressor response to PNS 
and NA infusion
ICI 118,551 (5x 10“7m ) alone had no significant effect on
i
the basal perfusion pressure or the pressor response to 
PNS and NA infusion in any of the preparations. 
Furthermore, ICI 118,551 had no significant effect on the 
angiotensin II induced potentiation of the pressor 
response to PNS and NA infusion in any of the preparations 
























Effect of ICI 118,551 on the angiotensin II (All)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of male and female two-kidney, 
one-clip renal hypertensive rats (WmR, WfR respectively), 
male and female sham-operated rats (Wm , Wf respectively) and 
male and female renal hypertensive rats treated chronically 
with ICI 118,551 (WmRI, WfRI respectively).










+ p<0.05, compared to control pressor response 
. p<0.01, compared to control pressor response 
* p<0.05, compared to sham-operated rats


















All ICI 118,551 AI1 + ICI 118,551
Fig 4.20
Effect of ICI 118,551 on the angiotensin II (All)-induced 
potentiation of the pressor response to exogenous NA in the 
isolated perfused mesenteric vasculatures of male and female 
two-kidney, one-clip renal hypertensive rats (WmR, WfR respectively), 
male and female sham-operated rats (Wm , Wf respectively) and male 
and female renal hypertensive rats treated chronically with 
ICI 118,551 (WmRI, WfRI respectively).
Vertical lines indicate s.e. of mean, n = 3 animals for each group. 
WmR Q  » , 0  WmRI 0
wfB E3 wi S  wfRI K
* p<0.05, compared to sham-operated rats 




The results described in this chapter suggest that 
physiological mechanisms facilitating sympathetic 
neurotransmission in the mesenteric vascular bed are 
enhanced in the renal hypertensive rats compared to the 
normotensive Wistars. Once again this facilitation seems 
to be quantitatively and qualitatively similar in male and 
female animals.
The results indicate that the facilitatory mechanisms are*
located presynaptically. This can be deduced from the 
comparison of the effects of isoprenaline and angiotensin 
II on the pressor response to PNS and NA infusion. It can 
be further concluded that the augmentation of presynaptic 
activity by isoprenaline is mediated via £ 2 “ 
adrenoreceptors and that of angiotensin II via presynaptic 
angiotensin II receptors.
Chronic treatment of the renal hypertensive animals with 
ICI 118,551 significantly attenuated the degree of 
progression of the hypertension.
The results further indicate that the attenuation of this 
form of hypertension could be due to the presynaptic $ 2 “ 
adrenoreceptor being antagonised by the chronic treatment 
with ICI 118,551.
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It can also be inferred from the studies with cocaine and 
angiotensin II that chronic administration of ICI 118,551 








Ethinyloestradiol was used for this study. Age matched 
(12-14 weeks old) male and female Wistar rats were used in 
this study. The ethinyl oestradiol (EO) treated groups 
received a subcutaneous injection of EO (1.5 mg/kg rat 
body weight) daily for three weeks. The age and sex 
matched controls received a subcutaneous injection of the 
vehicle, arachis oil, daily for three weeks.
For clarity in this chapter,
E0m - EO treated male Wistar
EOf - EO treated female Wistar
Wm - vehicle treated male Wistar
Wf - vehicle treated female Wistar
5.1ii Blood pressure measurements
Systolic blood pressure was monitored in the conscious 
animals by the tail-cuff method using a programmed 
electro-sphygmomanometer PE-300 (Narco bio-instruments) 
coupled to a flat-bed recorder (CR6505, J.J.Instruments)• 
Systolic blood pressure was monitored at the end of each 
week of EO treatment. The mean of three readings on that 
day was taken as the systolic blood pressure.
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The animals were weighed on the same day as the 
measurement of the systolic blood pressure,
5.1iii Isolated perfused tissues
Once the elevation of the systolic blood pressure had 
stabilized (after three weeks of EO treatment), the 
animals were sacrificed and the isolated perfused 
mesenteric vascular bed and the isolated perfused kidney 
preparations were set up as previously described in 
Section 2.2i. and Section 3.2i respectively.
Modified Kreb's solution (composition as described in 
Section 2.2i) was used as the perfusion medium for the 
mesenteric vascular preparation and Tyrode solution 
(composition as described in Section 3.2i) was used as the 
perfusion medium for the kidney preparation. The isolated 
mesenteric vascular preparation and the isolated kidney 
preparation were both taken from the same animal. The 
isolated kidney was cannulated and set up first, followed 
by the mesenteric vasculature from the same animal. 
Whilst the isolated kidney preparation was being set up 
care was taken to keep the mesenteric vasculature moist 
with the Kreb's solution. Not more than five minutes 
elapsed between the setting up of the * isolated kidney 
preparation and the setting up of the isolated mesenteric 
vasculature.
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The Kreb*s and Tyrode solutions were perfused at a 
constant rate of 5 ml/min and 10 ml/rain respectively by 
means of Watson Marlow peristaltic pumps. The perfusing 
solutions were aerated with a mixture of 95% oxygen and 5% 
carbon dioxide before passing through a warming coil 
maintained at 38°C. Changes in perfusion pressure were 
measured at a point close to the cannula by means of a 
pressure transducer (Bell and Howell, type 4-422-0001) and 
recorded on a Devices (M2) recorder.
After allowing time for the basal perfusion pressure to
stabilize, usually 15 minutes, the preparations were 
subjected to either PNS or to a bolus of NA. PNS was 
delivered at 30Hz, 80V, 1 msec pulse width for 10 seconds
duration for the mesenteric vascular preparation and 3Hz,
50V, 1 msec pulse width for 5 seconds duration for the
kidney preparation.
The amount of NA given in the NA infusion was such that 
the pressor response elicited in the two different
preparations was approximately similar to the PNS response 
in those preparations. The NA infusion was 0.1 ml of 
10“6m and 0.1 ml of 10~7m  of noradrenaline bitartrate 
solution for the mesenteric and kidney preparations 
respectively.
Once stable responses to PNS and NA infusion had been 
demonstrated, perfusion with other drugs began. The
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method of perfusion of the drugs was as described 
previously in Section 2.2i.
Data was derived from the second response to PNS or NA 
infusion; the exception being experiments involving 
cocaine, when the first response was taken.
PNS and NA response data after drug perfusion in the 
preparations are expressed as a percentage of the control 
pressor response in order to standardize the data.
Age matched male and female Wistar rats (University of 
Bath strain) were used in this study. The animals used 
were supplied by the University of Bath Animal House.
5.1iv Statistical Analysis
Results were analysed using Student’s t-test for group and 
paired mean comparisons.
Probability levels equal to or less than 0.05 were taken 
as indicating statistically significant differences. All 
comparisons employed the two-tailed test.
All data is taken from measurements and results from 




5.2i Effect of chronic treatment with EO on the weight 
and systolic blood pressure of the animals
Figs 5.1 and 5.2 show the effect of chronic treatment with
EO for three weeks on the weight and systolic blood
pressure respectively.
As can be seen from Fig 5.1, both male and female rats
treated chronically with EO lost weight significantly
compared to control rats. The degree of weight loss in 
the male EO treated animals was significantly greater than 
that in the female EO treated animals; 17.69 + 0.54% for 
the male EO treated and 12.28 + 0.89% for the female EO 
treated animals (p<0.001).
The systolic blood pressure was also significantly higher 
in the EO treated groups compared to the control groups. 
Fig 5.2. This elevation remained stable at least up to 
four weeks of EO treatment when the treatment was 
continued further beyond the three weeks. The elevation 
of the blood pressure caused by the chronic treatment with 
















Effect of chronic treatment with ethinyloestradiol (EO) on the 
weights of Wistar rats.
Vertical lines indicate s.e. of mean, 
n = 15 animals for each group.
EO-treated male Wistar rats 
EO-treated female Wistar rats 
Vehicle-treated male Wistar rats 
Vehicle-treated female Wistar rats f\J 
























Effect of chronic treatment with ethinyloestradiol (E0) on the 
systolic blood pressure of Wistar rats.
Vertical lines indicate s.e. of mean, 
n - 15 animals for each group.
EO-treated male Wistar rats 
EO-treated female Wistar rats 
Vehicle-treated male Wistar rats 





+ p(0.05, compared to vehicle-treated rats. 
* p<0,05, compared to EO-treated male rats.
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5.2ii Effect of chronic treatment with EO on the pressor 
responses to PNS and NA infusion in the mesenteric 
and kidney preparations
Chronic treatment with EO significantly sensitized the 
mesenteric and kidney vasculature to NA in both the male 
and female animals. The pressor response to PNS in the 
animals chronically treated with EO was also enhanced 
compared to the control animals (vehicle treated). No 
significant differences in the degree of EO induced 
potentiation of pressor responses to PNS and NA infusion 
between the preparations from male and female animals were 
observed. Figs 5.3 and 5.4.
5.2iii Effect of chronic treatment with EO on the weight 
of the adrenal glands of the animals
Table 5.1 shows the mean wet weight of the adrenal glands 
of the animals used in this study.
The adrenal glands from the animals chronically treated 
with EO were found to be significantly heavier than those 
from the sex-matched controls, though no significant 






















Pressor response to PNS and noradrenaline (NA) Infusion In the 
Isolated perfused mesenteric vasculature of rats treated 
chronically with ethinyloestradlol (EO) and rats treated with 
vehicle.
Vertical lines Indicate s.e. of mean,
n ~ 15 animals for each group
EO-treated male rats j^ J Vehicle-treated male rats \/\
EO-treated female rats f^ j Vehicle-treated female rats [\J























Pressor response to PNS and noradrenaline (NA) infusion in the 
isolated perfused kidney of rats treated chronically with 
ethinyloestradiol (EO) and rats treated with vehicle 
Vertical lines indicate s.e. of mean, 
n = 15 animals for each group.
EO-treated male rats □  Vehicle-treated male rats
EO-treated female rats B Vehicle-treated female rats
* p(0.05 compared to vehicle-treated rats
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Table 5.1
Wet weight of adrenal glands from rats treated 
chronically with ethlnyloestradiol (EO) and rats 
treated with arachis oil (vehicle)






Male 49.2 + 3.4 + 61.6 + 3.1
rats (10) (10)
Female 48.9 + 3.1 + 59.7 + 2.8
rats (10) (10)
Values are mean + s.e. of mean 
Number in parenthesis, number of animals. 
+ p<0.05, significant differences from 
sex-matched vehicle treated rats.
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5.2iv Effect of isoprenaline on the pressor responses to 
PNS and NA infusion in the rats chronically treated 
with EO
a) Mesenteric vascular bed
Isoprenaline (5x 10“8m ) was used as the standard 
concentration in this study, and in following studies 
described in this chapter, as this concentration caused 
the greatest potentiation of the pressor response to PNS 
in the Wistar rats (Section 2.3ii).
Fig 5,5 shows the effect of isoprenaline on the pressor 
response to PNS and NA infusion in the preparations from 
rats treated with arachis oil and rats treated chronically 
with EO.
Isoprenaline caused a potentiation of the pressor response 
to PNS in the preparations from all the groups. This 
potentiation was however significantly greater in the 
preparations from animals treated chronically with EO than 
in those from the control animals.
There were no significant differences between the 
preparations from male and female animals from each group.
Isoprenaline caused an inhibition of the pressor response 
to NA infusion in all the preparations from all the 
groups. The degree of this inhibition was similar in all 























Effect of isoprenaline on the pressor responses to PNS and 
exogenous noradrenaline (NA) in the isolated perfused mesenteric 
vasculature of rats treated chronically with ethinyloestradiol 
(EO) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, 
n = 3 animals for each group.
EO-treated male Wistar rat 
EO-treated female Wistar rat 
Vehicle-treated male Wistar rat 





-f-p(0.05, all groups in these sections significantly different 
compared to control pressor response.
+ p^0.05, compared to vehicle-treated rats.
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Isoprenaline alone had no significant effect on the basal 
perfusion pressure of any of the preparations from any of 
the groups,
b) Kidney vasculature
The standard concentration of isoprenaline used for the 
isolated kidney preparation in this and following studies 
described in this chapter was 10“®M and 1 0 "^m f0r kidneys 
from male and female animals respectively, as these 
concentrations caused the greatest potentiation of the
pressor response to PNS in the preparations from Wistar 
rats (Section 3.3ii).
Fig 5,6 shows the effect of isoprenaline on the pressor 
response to PNS and NA infusion in the preparations from 
animals treated with the vehicle and animals treated
chronically with EO,
Isoprenaline alone had no significant effect on the basal 
perfusion pressure of the preparation from any of the
animals, however isoprenaline significantly potentiated 
the pressor response to PNS in all the preparations from 
all the animals. This potentiation was significantly 
greater in the preparations from EO treated animals than 
that from the vehicle-treated animals. No significant 
differences in the potentiation of the PNS response 


























Effect of isoprenaline on the pressor responses to PNS and 
exogenous noradrenaline (NA) in the isolated perfused kidneys 
from rats treated chronically with ethinyloestradiol (E0) 
and rats treated with vehicle 
Vertical lines indicate s.e. of mean, 
n = 3 animals for each group
EO-treated male Wistar rats
EO-treated female Wistar rats
%
Vehicle treated male Wistar rats 





.05 all groups in these sections significantly different
compared to control pressor response.
+ p<0.05, compared to vehicle-treated rats.
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Isoprenaline caused an inhibition of the pressor response 
to NA infusion in all the preparations from all the 
groups. The degree of this inhibition was similar in all 
the preparations.
5.2v Effect of ICI 118,551 on the isoprenaline induced 
effects on the pressor responses to PNS and NA 
infusion
ICI 118,551 (5x10-7m ) alone had no significant effect on 
the basal perfusion pressure or the pressor response to
PNS and NA infusion in any of the preparations. However,
ICI 118,551 significantly abolished the isoprenaline 
induced potentiation of the pressor response to PNS in all 
the preparations.
ICI 118,551 (5x 10“7m ) significantly reversed the
isoprenaline induced inhibition of the pressor response to 
NA infusion in all the preparations. Fig 5.7 and Fig 5.8 
for mesenteric and kidney preparations respectively.
5.2vi Effect of atenolol on the isoprenaline induced 
effects on the pressor responses to PNS and NA 
infusion
Atenolol (lO'^M) alone had no significant effect on either 
the basal perfusion pressure or the pressor response to

























Effect of ICI 118,551 (ICI) on the isoprenaline (Iso)-induced 
effects on the pressor responses to PNS and noradrenaline (NA) infusion 
in the isolated perfused mesenteric vasculature of rats treated 
chronically with ethinyloestradiol (E0) and rats treated with 
vehicle.
Vertical lines indicate s.e. of mean, n - 3 animals for each group 
EO-treated male rats Vehicle-treated male rats [/I
EO-treated female rats |— -| Vehicle-treated female rats hsj
%
+ p<0.05 compared to control pressor response and all other sections 




























Effect of ICI 118,551 (ICI) on the isoprenaline (Iso)-induced 
effects on the pressor responses to PNS and noradrenaline (NA)infusion 
in the isolated perfused kidney of rats treated chronically 
with ethinyloestradiol (EO) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group
EO-treated male rats □ Vehicle-treated male rats
EO-treated female rats B Vehicle-treated female rats £\J
+ p(0.05 compared to control pressor response and all other sections 
* p<0.05 compared to vehicle-treated rats
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Atenolol did not significantly affect the isoprenaline 
induced potentiation of the pressor response to PNS in any 
of the preparations.
In all the preparations, atenolol significantly reversed 
the isoprenaline induced inhibition of the pressor 
response to NA infusion. Figs 5.9 and 5.10 for mesenteric 
and kidney preparations respectively.
5.2vii Effect of angiotensin II on the pressor responses 
to PNS and NA infusion
The concentrations of angiotensin II (All) employed in 
this study were 10 ng/ml and lng/ml for the mesenteric and 
kidney preparations respectively. At the concentrations 
employed in this study, angiotensin II caused an initial 
transient elevation of the basal perfusion pressure
(approximately 15%) in some of the preparations. This 
transient elevation of the basal perfusion pressure
usually lasted for about 60 seconds before returning to 
its pre-angiotensin II perfusion levels. Further
perfusion of angiotensin II caused no discernible effect 
on the basal perfusion pressure.
Table 5.2 shows the effect of NA infusion in the 
mesenteric and kidney preparations of animals treated 




























Effect of atenolol (Aten) on the isoprenaline (Iso)-induced
effects on the pressor responses to PNS and noradrenaline (NA) infusion
in the isolated perfused mesenteric vasculature of rats
treated chronically with ethinyloestradiol (E0) and rats
treated with vehicle.
Vertical lines indicate s.e. of mean, n - 3 animals for each 
group.
E.0.-treated male rats | | Vehicle-treated male rats j^TJ
EO-treated female rats Vehicle-treated female rats £ \ J
+ p^0.05 compared to control pressor response and all other sections 






















Aten Iso + 
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Effect of atenolol (Aten) on the isoprenaline (Iso)-induced
effects on the pressor responses to PNS and noradrenaline (NA) infusion
in the isolated perfused kidney of rats treated chronically
with ethinyloestradiol (E0) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group
EO-treated male rats □ Vehicle-treated male rats
EO-treated female rats {^ j Vehicle-treated female rats
+ p<0.05 compared to control pressor response and all other sections 
* p^0.05 compared to vehicle-treated rats
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Table 5.2
Effect of angiotensin II (All) on the pressor response to 
noradrenaline (NA) Infusion in the isolated mesenteric 
and kidney preparations from rats treated chronically with 





All + NA 
infusion 












EO-treated, male 14.3 + 1.2 18.5 + 1.5 129.4 + 3.1
Vehicle-treated, 
male





EO-treated, female 14.6 + 1.4 18.3 + 0.6 125.3 + 2.4
Vehicle-treated, 
female
9.8 + 1.3 
*









EO-treated, male 25.1 + 1.3 31.4 + 1.6 125.1 + 3.3
Vehicle-treated, 
male
9.8 + 1.4 
*
12.1 + 1.4 
*
123.5 + 1.6
EO-treated, female 23.3 + 1.7 29.6 + 1.6 127 +2.3
Vehicle-treated, 
female





Values are mean + s.e. of mean 
n - 3 animals for each group
* p(0.05 compared to sex-matched EO-treated rats
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As can be seen from Table 5.2, angiotensin II caused a 
slight, but significant, potentiation of the pressor
response to the NA infusion in all the preparations, but 
the degree of this potentiation was similar in all the 
preparations indicating that the EO treatment did not
significantly affect the angiotensin II receptor.
Angiotensin II significantly potentiated the pressor 
response to PNS in the mesenteric and kidney preparations 
of all groups. The degree of this potentiation was found 
to be similar in the animals treated chronically with EO 
and with vehicle; thus indicating that EO treatment had no 
significant effect on the angiotensin II receptors.
Table 5.3.
No significant difference between the All induced 
potentiation of the pressor response to PNS and NA
infusion was found in any of the preparations from any of 
the groups.
5.2viii Effect of angiotensin II converting enzyme (ACE) 
inhibitor on the isoprenaline induced effects 
on the pressor response to PNS and NA infusion
Captopril (5xlO“^M) was used as the ACE inhibitor in this 
study. Captopril had no significant effect on the basal 
perfusion pressure or the pressor response to PNS and NA 
infusion in any of the preparations. However, captopril 
effectively inhibited the isoprenaline induced
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Table 5.3
Effect of angiotensin II (All) on the pressor response 
to PNS In the isolated mesenteric and kidney preparations 























EO-treated, male 12.1 + 1.3 15.4 + 1.7 127.6 + 2.1
Vehicle-treated
male
8.8 + 1.6 
*
11.1 + 1.4 
*
126.4 + 1.8
EO-treated, female 13.1 + 1.6 17.2 + 1.6 129.7 + 1.4
Vehicle-treated, 
female
9.6 + 1.4 
*









EO-treated, male 20.8 + 2.2 26.8 + 2.4 129.1 + 2.6
Vehicle-treated, 
male
13.4 + 1.6 
*





22.4 + 1.9 27.5 + 1.6 123.7 + 2.8
Vehicle-treated, 
female
15.1 + 2.1 
*
19.1 + 1.8 
*
125.5 +1.4
Values are mean + s.e. of mean 
n = 3 animals for each group
* p<0.05 compared to sex-matched EO-treated rats
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potentiation of the pressor response to PNS (Figs 5,11 and 
5.12 for mesenteric and kidney preparations, respectively) 
in all the preparations whilst not having any significant 
effect on the isoprenaline induced inhibition of the 
pressor response to NA infusion (Figs 5.13 and 5.14 for 
mesentery and kidney preparations respectively) in any of 
the preparations.
5.2ix Effect of [Sar^-Ile^] angiotensin II (Sar) on the 
isoprenaline induced effects on the pressor 
responses to PNS and NA infusion
Sar (200 ng/ml) by itself had no significant effect on the 
basal perfusion pressure or the pressor response to PNS 
and NA infusion in any of the preparations. Sar however 
effectively inhibited the isoprenaline-induced 
potentiation of the pressor response to PNS (Figs 5.15 and 
5.16 for mesentery and kidney preparations respectively) 
in all the preparations, whilst not having any significant 
effect on the isoprenaline induced inhibition of the 
pressor response to NA infusion (Fig 5.17 and 5.18 for 
mesentery and kidney preparations, respectively) in any of 





















Iso Capt Iso + Capt
Fig 5.11
Effect of captopril (Capt) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused mesenteric vasculature of rats treated chronically 
with ethinyloestradiol (EO) and rats treated with vehicle. 
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group.
EO-treated male rats □ Vehicle-treated male rats
EO-treated female rats |— ~| Vehicle-treated female rats
+ p<0.05 compared to control pressor response and all other sections 























Effect of Captopril (Capt) on the isoprenaline (Iso)-induced 
potentiation of the pressor response to PNS in the isolated 
perfused kidney from rats treated chronically with 
ethinyloestradiol (E0) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for 
each group.
EO-treated male rats [^ ] Vehicle-treated male rats j/j
EO-treated female rats p^[ Vehicle-treated female rats
+ p{0.05 compared to control pressor response and all other sections 























Capt Iso + CaptIso
Fig 5.13
Effect of Captopril (Capt) on the isoprenaline (Iso)-induced 
inhibition of the pressor response to exogenous NA in the 
isolated perfused mesenteric vasculature of rats treated 
chronically with ethinyloestradiol (E0) and rats treated 
with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for 
each group.
EO-treated male rats □  Vehicle-treated male rats |
EO-treated female rats B Vehicle-treated female rats ]
fp<° .05 significant difference between groups of these























Iso + CaptIso Capt
Fig 5.14
Effect of Captopril (Capt) on the isoprenaline (Iso)-induced 
inhibition of the pressor response to exogenous NA in the 
isolated perfused kidney of rats treated chronically with 
ethinyloestradiol (EO) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, n - 3 animals for
each group
EO-treated male rat □  Vehicle-treated male rat
EO-treated female rat |ZZJ Vehicle-treated female rat
-fp<o .05, significant difference between groups in these









Iso Iso + Sar
Fig 5.15
Effect of [sar^-Ile8] angiotensin II (Sar) on the isoprenaline 
(Iso)-induced potentiation of the pressor response to PNS 
in the isolated perfused mesenteric vasculature of rats treated 
chronically with ethinyloestradiol (E0) and rats treated 
with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group.
EO-treated male rat □ Vehicle-treated male rat
EO-treated female rat Vehicle-treated female rat
+ p<0.05 compared to control pressor response and to groups 
in all other sections








Iso Iso + SarSar
Fig 5.16
Effect of [sar1 -lie3  angiotensin II (Sar) on the isoprenaline 
(Iso)-induced potentiation of the pressor response to PNS in 
the isolated perfused kidney of rats treated chronically with 
ethinyloestradiol (E0) and rats treated with vehicle.
Vertical lines indicate s.e. of mean, n = 3 animals for each 
group
EO-treated male rat □  Vehicle-treated male rat 0
EO-treated female rat B  Vehicle-treated female rat □
+ p(0.05 compared to control pressor response and to groups in 
all other sections























iso Iso + SarSar
Fig 5.17
P i slEffect of [Sar -lie J angiotensin II (Sar) on the isoprenaline 
(Iso)-induced inhibition of the pressor response to exogenous 
NA in the isolated perfused mesenteric vasculature of rats 
treated chronically with ethinyloestradiol (E0) and rats 
treated with vehicle.








“|“p^0.05, significant differences between groups in these
























Sar-Iso. Iso + Sar
Fig 5.18 _
Effect of |^ Sar1-Ile8J angiotensin II (Sar) on the isoprenaline 
(Iso)-induced inhibition of the pressor response to exogenous 
NA in the isolated perfused kidney of rats treated chronically 
with ethinyloestradiol (E0) and rats treated with vehicle. 










.05, significant differences between groups in these




The results indicate that chronic treatment with EO
induces hypertension in rats and that this is greater in
female rats than in male rats.
Chronic administration of EO also causes a weight 
reduction in the animals, the effect being greater in male
rats than in female rats.
The significant increase in weight of the adrenal glands 
in the EO treated animals could be associated with the 
hypertrophic appearance of the gland in the EO treated 
animal compared to the vehicle treated animals.
Increased vascular sensitivity to NA of perfused 
mesenteric beds and kidney preparations was observed after 
chronic EO treatment. The EO treatment, however, did not 
affect the vascular sensitivity to angiotensin II or the 
postsynaptic sensitization of adrenergic receptors by 
angiotensin II.
Chronic treatment with EO seemed to augment physiological
mechanisms facilitating sympathetic neurotransmission in
%
the mesentery and kidney vasculature. This facilitation 
seems to be qualitatively and quantitatively similar in 
male and female rats. That the facilitatory mechanism is 
located presynaptically can be inferred from the 
comparison of the effects of isoprenaline on the pressor
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response to PNS and NA infusions. It can be further 
concluded that the augmentation of presynaptic activity by 
isoprenaline is mediated via ^2"a(^ renorecePtors • Chronic 
treatment with EO enhanced the presynaptic £ 2 “ 
adrenoreceptor activity because the isoprenaline further 
enhanced the pressor response to PNS in the animals 
treated chronically with EO compared to the animals 
treated with arachis oil. However, no increased activity 
or sensitivity of the pre-synaptic angiotensin II receptor 
was noted in relation to the chronic treatment with EO.
182
Chapter 6
PLASMA NORADRENALINE AND ADRENALINE LEVELS: ANALYSIS BY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
6.1 Introduction
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This chapter is devoted to the quantification of 
circulating plasma NA and Ad levels in all the strains and 
types of rats used.
Firstly, the plasma catecholamine levels were measured at 
different ages (3 weeks to 15 weeks) in the SH and Wistar 
rat in order to ascertain if there were any differences, 
or similarities, between the two strains and between the 
sexes of each strain.
The catecholamine level was also measured in the "Goldblatt 
two— kidney, one — clip** renal hypertension model and 
compared with the SH and control Wistar animals. The age 
of the rats used in this study was 12 weeks to 15 weeks.
As shown in Chapter 4, chronic ICI 118,551 (25 mg/kg p.o. 
daily) treatment tended to reduce the degree of 
hypertension in the renal hypertensive model. Therefore 
the catecholamine levels were also measured in the chronic 
ICI 118,551 - treated renal hypertensive models.
Chronic ethinyloestradiol (EO) treatment tended to 
increase the blood pressure of the Wistar rats (see 
Chapter 5) and therefore the effect of the chronic EO 
treatment on plasma NA and Ad levels was investigated. 
Chronic EO treatment consisted of a subcutaneous injection
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of EO, 1.5mg/kg, daily for three weeks. Wistar rats aged 
twelve to fourteen weeks were used for this study.
In all experiments, the blood samples from the animals 
were obtained by cardiac puncture under ether anaesthesia.
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6.2 Methods
6.2i Collection of blood samples
Blood samples for catecholamine analysis were collected by 
cardiac puncture. Approximately 4ml of blood was taken 
from each animal and put into chilled glass tubes 
containing lOOul of 0.2M reduced glutathione (GSH, Sigma) 
and lOOul of heparin (1000 U/ml). The blood was 
centrifuged at 2000 r.p.m. for 10 minutes at 4°C (MSE, 
Chillspin) to separate the plasma phase, and the plasma 
samples were stored frozen at -25°C until assayed.
6.2ii Determination of plasma catecholamines
Plasma samples were assayed for adrenaline (Ad) and 
noradrenaline (NA) content by a modification of the method 
described by Eriksson and Persson (1982), utilizing 
alumina extraction and analysis of the extracts by high 
performance liquid chromatography (HPLC).
6.2iii Preparation of alumina (aluminium oxide)
Aluminium oxide was activated in order to obtain the grade 
recommended by Anton and Sayre (1962). 100 grammes of
aluminium oxide (Brockmann grade, neutral, BDH) was added 
to 500 ml of 2M HC1 in a beaker, covered and heated to 
90°-100°C on a hot plate. The temperature was monitored 
with a thermometer and the aluminium oxide was
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continuously stirred with a magnetic stirrer for 45 
minutes at this temperature. The aluminium oxide was then
allowed to settle and the yellow supernatant fluid was
discarded along with the finer alumina particles.
The precipitate was washed twice with fresh 250ml portions 
of 2M HC1 at 70oc for 10 minutes, discarding the
supernatant each time. In the final acid wash, the
alumina was stirred in 500ml of 2M HC1 at 50°C for 10
minutes. After decanting the HC1, the precipitate was
repeatedly washed (20 times) with fresh 200ml volumes of 
distilled water until the supernatant had a pH of 3.4.
Finally, the aluminium oxide was transferred to an 
evaporating dish and heated at 120°C for 1 hour and at 
200°C for a further 2 hours in an oven. The alumina was 
then stored in a capped glass bottle in a dessicator at 
room temperature.
6.2iv Extraction procedure
1.5ml portions of plasma samples were placed in Eppendorf 
tubes to which 50 pmoles of the internal standard, 3,4- 
dihydroxybenzylamine (DHBA , Sigma) dissolved in 0.2M 
perchloric acid, had been added. The samples were well 
mixed and transferred to plastic tubes containing 50jj1 of 
50mM reduced glutathione (GSH, Sigma), 50ul of 300mM 
ethylenediaminetetra-acetic acid disodium salt (EDTA,BDH) 
and 25mg of the activated alumina. 0.2ml of 1M Tris
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buffer (pH 8,6), prepared by mixing 1M solutions of Trizma 
base and Trizma hydrochloride (both from Sigma), was then 
added to the samples. The sample tubes were capped,
manually shaken and mixed on a Luckham rotary mixer for 20 
minutes•
After the mixing, the tubes were centrifuged at 1000 
r.p.m. for 5 minutes (IEC Centra-7.) to settle the alumina 
and the supernatant was discarded. The alumina was washed 
3 times with a 3mM EDTA solution (pH 7.0), centrifuging 
between washes and discarding the supernatant. After the 
final wash with the 3mM EDTA the samples were centrifuged 
and the supernatant discarded. 200^il of 0.2M perchloric 
acid was then added to the alumina, mixed for 10 minutes 
and the sample tubes centrifuged at 100 r.p.m. for 5 
minutes. 150pl of the supernatant was then pipetted out 
and stored frozen at -25°C until HPLC analysis.
6.2v Assay of plasma extracts for catecholamines
by high performance liquid chromatography (HPLC)
The adrenaline (Ad) and noradrenaline (NA) contents of the 
perchloric acid extracts were determined by reversed 
phase, ion-pair HPLC with electro-chemical detection.
The liquid chromatograph was composed of an LDC Model III 
Constametric pump, a Rheodyne 7125 injection valve with a 
50ul loop, a 25 cm x 4.6 mm i.d. stainless steel 
analytical column packed with 5 urn diameter Spherisorb-ODS
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particles (Anachem) and a BAS LC-4A amperometric detector. 
The detector was operated at +0.65v with an Ag/AgCl 
reference electrode (BAS RE-1) and a glassy carbon working 
electrode. The flow rate of the mobile phase was kept 
constant at l.Oml/min.
The mobile phase consisted of an acetate/citrate buffer 
(pH 5.2) containing 5% methanol (HPLC grade, Fisons) and 
0.5mM 1-octanesulphonic acid sodium salt (HPLC grade, 
Fisons), the ion pairing agent.
The composition of the acetate/citrate buffer was (mM):
Sodium acetate, 100; Sodium hydroxide, 60; citric acid, 
40.
The water used for the mobile phase was deionized and 
filtered by a Millipore Milli-Q water purification system. 
Prior to use, the mobile phase was filtered under vacuum 
and degassed by vigorously bubbling helium through the 
solution for 20 minutes.
Chromatograms were recorded on a JJ Instruments flat-top 
recorder. Typical chromatograms from a plasma extract and 
a non-extracted standard solution are shown in figure 6.1. 
Peak heights were measured manually and peak height ratios 













5 min 5 min
Typical examples of chromatograms from
a) extracted plasma sample
b) non-extracted standard sample




Aliquots of 50 pmoles of DHBA in 0.2M perchloric acid were 
added to 1,5ml portions of known increasing concentrations 
of NA and Ad in the Eppendorf tubes and the samples 
underwent the extraction procedure previously described in 
section 6/2 iv.
The peak height ratios (NA/DHBA and Ad/DHBA) were plotted 
against the catecholamine concentrations to obtain 
calibration curves for both Ad and NA. Typical 
calibration curves are shown in Fig 6,2. These curves 
were used to convert peak height ratios to concentration 
values (pmol/ml) when analysing the plasma samples.
6.2vii The linearity of the detector response 
and the extraction procedure
The linearity of the detection system was evaluated by 
injecting standard solutions directly into the 
chromatographic system. The solutions contained
increasing amounts of adrenaline and noradrenaline and a 
fixed concentration of DHBA in 0.2M perchloric acid.
The linearity of the extraction procedure was tested by 
putting increasing concentrations of NA and Ad samples 
through the extraction procedure. The internal standard, 
DHBA, was not added to the samples at the beginning of the 











































10 20 40 80
Plasma Ad concentration (p mol/ml)
Fig 6.2 Caliberation curves for (a) noradrenaline (NA), and
(b) adrenaline (Ad). DHBA = 3,4-dihydroxybenzylamine. 
Each point is the mean of three determinations. 
Vertical lines indicate s.e. of mean.
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acid used for the final elution, at the appropriate 
concentration. The extracts were then analysed by HPLC 
and the peak height ratios calculated.
Both the detector response and the extraction procedure 
were found to be linear within the range corresponding to 
plasma concentrations of 2.5-40 pmol/ml for noradrenaline 
and 5-80 pmol/ml for adrenaline (r 0.99).
6.2viii Calculation of recovery
The recovery of noradrenaline and adrenaline was
calculated by comparing the peak height ratios from the
alumina extraction of spiked catecholamine samples with 
the peak height ratios from direct injections of the same 
concentrations of catecholamines into the chromatogram.
The recovery of DHBA was calculated by comparing the peak 
height ratios obtained during the construction of
calibration curves with those obtained when the DHBA was 
added during the final elution.
The recoveries for adrenaline, noradrenaline and DHBA were 
found to be 57%, 57% and 58% respectively.
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6.3 Results
6.3i Effect of age on the plasma NA and Ad
levels in the SH and Wistar rat.
Figs 6.3 and 6.4 show the plasma levels of NA and Ad, 
respectively, in the SH and age matched control Wistar 
animals•
At the ages studied in this experiment, the SH animals had 
significantly higher plasma NA and Ad levels, than their 
respective Wistar controls. No significant differences in 
the plasma catecholamine levels between the male and 
female animals of each strain was found.
6.3ii Effect of renal hypertension on plasma NA 
and Ad levels
Wistar male and female animals were used.
Renal hypertension was induced by the two kidney, one clip
method as previously described in Chapter 4. After the 
animals attained a state of established elevated blood 
pressure, usually after 12 weeks, they were anaesthetized 
with ether and the blood was obtained by cardiac puncture.
Table 6.1 shows the plasma levels of NA and Ad in the 



























3 6 9 12 15 18
Age of rats (weeks)
Fig 6.3. Effect of age on the plasma NA levels in the male SH 
(....), female SH (x...x), male Wistar («_«) and 
female Wistar (x— x) rats, for each point.
Vertical lines indicate s.e. of mean (most omitted 
for clarity), n = 8 animals.
At all points, plasma NA levels in SH rats significantly 





























Fig 6.4 Effect of age on the plasma Ad levels In the male
SH (•-- •) , female SH (x x) , male Wistar (•--- •)
and female Wistar (x x) rats.
Vertical lines Indicate s.e. of mean (most omitted 
for clarity), n = 8 animals for each point.
At all points, plasma Ad levels in SH rats significantly 
greater than that in Wistar rats (p 0.05).
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Table 6.1
Plasma levels of NA and Ad in renal hypertensive 








male Wistar rat 12.8 + 0.4 23.3 + 0.7




12.8 + 0.3 24.6 + 0.5
Control female 4.4 + 0.5 7.2 + 1.4
Wistar rat
Values are given as mean s.e. of mean n - 10 animals 
for each group.
Plasma NA and Ad levels significantly greater in renal 
hypertensive rats than that in sham operated rats ( p<0.01)
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The plasma levels of NA and Ad were significantly elevated 
(p<0.01) in the renal hypertensive animals compared to the 
control animals. This elevation was found to be 
significantly greater (p<0.05) than the plasma NA and Ad 
levels in the sex and age matched SH animals. Table 6.2.
6.3iii Effect of chronic IC1 118,551 treatment
on the plasma NA and Ad levels in the renal 
hypertensive animals
The plasma levels of NA and Ad in the chronically ICI 
118,551— treated renal hypertensive animals are shown in 
Table 6.2. The plasma catecholamine levels were not 
significantly different from those in the sex- and age- 
matched SH animals but significantly lower than those of 
the untreated renal hypertensive animals.
No significant difference in the plasma catecholamine 





Plasma NA and Ad levels In male and female SH rats 
(SHR^ and SHR^. respectively^. male and female renal 
hypertensive rats (W R^ and W^R. respectively^ and male 
and female renal hypertensive rats treated chronically 
with IC.I 118,551 (W^RI and W^RI, respectively)
Plasma NA Plasma Ad
concentration concentration
(pmol/ml) (pmol/ml)
W R m + 12.8 + 0.4 + 23.3 + 0.7
SHRm 10.4 ± 0.5 19.4 + 1.7






SHRf 10.5 + 0.6 20.5 + 2.1
WfRI 9.8 + 0.8 16.7 + 3.1
Values are given as mean + s.e of mean 
n s 10 animals for each group 
+ p(0.05 compared to all other groups
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6.3iv Effect of ethinyloestradiol (EO) treatment 
on the plasma NA and Ad levels
Table 6,3 shows the plasma NA and Ad levels of Wistar 
animals treated chronically with EO (1.5mg/kg sub 
cutaneously for three weeks) and with the vehicle.
The plasma NA and Ad levels are elevated in the chronic EO 
treated animals compared to the vehicle treated animals. 
The plasma Ad levels in the EO treated females tended to 




Plasma NA and Ad levels In male and female rats
chronically treated with ethinyloestradiol (EO and EO
respectively) and in male and female rats treated *’







EOm 7.8 ± 0.7 13.6 + 1.2
Wm 4.9 ± 0.8 9.0 + 1.4
E0„
f 7.6 ± 0.8 15.4 ± 0.8
wt 4.8 ± 0.6 9.3 + 0*9
Values are given as mean + s.e. of mean 
n - 10 animals for each group 
Plasma NA and Ad levels in EO and EO 
significantly greater than i n V  and W _
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6.4 Discussion
The results indicate that the SHR rat generally had an 
elevated plasma NA and Ad level compared to age matched 
Wistar rats. Previous reports (McCarty et al, 1978; 
Popper et al, 1977) indicate that there is no significant 
difference in the circulating plasma NA and Ad levels 
between the SH and the Wistar Kyoto (Control) animals. 
However, McCarty et al (1978) measured basal sympatho­
adrenal activity in the undisturbed rat via an indwelling 
arterial cannula.
Renal hypertension in the Wistar rat tended to elevate the 
plasma catecholamine levels compared to the control 
animals and the plasma catecholamine levels were 
significantly greater than those in the SH animals. ICI 
118,551 treatment tended to decrease the increased blood 
pressure (see Chapter 4) in the renal hypertensive 
animals; the ICI 118,551 treatment also decreased the 
plasma catecholamine levels in the renal hypertensive rat.
Chronic EO treatment also elevated the circulating 
catecholamine plasma levels though not as high as in the 
SHR or renal hypertensive rats.
It therefore seems that sympatho-adrenal activity plays an 
important role in the maintenance and persistence of the 
three forms of hypertension described here.
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Drugs used
dl - Propranolol hydrochloride ICI Pharmaceuticals Ltd
dl - Isoprenaline hydrochloride ICI Pharmaceuticals Ltd
ICI 118,551 as the hydrochloride ICI Pharmaceuticals Ltd
Atenolol hydrochloride ICI Pharmaceuticals Ltd
Angiotensin II (human) Acetate Sigma Chemicals Ltd
dl - Noradrenaline bitartrate Sigma Chemicals Ltd
[Sar^-IleS] angiotensin II Sigma Chemicals Ltd
17OC- Ethinyloestradiol Sigma Chemicals Ltd
Guanethidine (Ismelin) Giba/Geigy 
Pharmaceuticals Ltd
Cocaine hydrochloride Vestric Ltd (Bristol)
Captopril Squibb Pharmaceuticals 
Ltd
Atenolol, ICI 118,551, isoprenaline and propranolol were 




7.1 Enhanced presynaptic P^-adrenoreceptor-mediated
modulation of vascular adrenergic neurotransmission 
in Spontaneously Hypertensive rats and New Zealand 
Hypertensive rats
The results described in this thesis demonstrate that the 
p-adrenoreceptor agonist, isoprenaline, potentiated the 
pressor response induced by peri-arterial nerve
stimulation of the mesenteric vascular bed and the kidney 
vasculature without affecting the basal perfusion
pressure. This potentiation was enhanced in . the 
preparations from SH and NZH rats compared to those from 
the Wistar and NZN rats.
In the preparations taken from the normotensive rats, low 
concentrations of isoprenaline (10“H m  to 5x 10“8m )
progressively potentiated the effect of PNS; at higher 
concentrations of isoprenaline the potentiation was
replaced by a concentration-dependent inhibition of the 
pressor response to PNS.
In the preparations from hypertensive rats, a similar 
shaped curve was obtained; in the mesenteric vascular 
preparation the potentiation of the pressor response to 
PNS was significantly greater than that in the respective 
normotensive rats at all concentrations of isoprenaline. 
However, in the isolated kidney preparations, the 
potentiation of the PNS pressor response was
significantly greater in the hypertensive rats than in the
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respective normotensive rats at the lower isoprenaline 
concentrations (<10“®M), but no inhibition of the pressor 
response to PNS was observed in the preparations from 
hypertensive animals at higher concentrations of 
isoprenaline. This might be attributed to the kidney 
vasculature being a complex integration of tissues and 
various humoral and neurohumoral agents interfering with 
the isoprenaline-induced potentiation of the pressor 
response to PNS. For example, it has been reported that 
in the rabbit kidney, prostaglandin E 2  dose-dependently 
and reversibly inhibited NA overflow resulting from renal 
nerve stimulation (Frame et al, 1975).
The biosynthesis of prostaglandins has been shown to be 
ten times greater in the medulla than in the cortex of the 
kidney, though the cortical synthesis is large enough to 
be of significance (Larsson and Anggard, 1973). The renal 
cortex also possesses an abundant amount of the 
prostaglandin degrading enzyme, prostaglandin
dehydrogenase (Anggard, Larsson and Samuelsson, 1971), and 
it is possible that endogenous cortical prostaglandin 
which escapes degradation may have access to the cortical 
nerve endings and affects neurotransmitter release. The 
effects of all the various humoral and neurohumoral agents 
found in the kidney vasculature on the isoprenaline 
induced effects on the pressor responses to PNS and NA are 
beyond the scope of research presented in this thesis; 
suffice it to say that isoprenaline caused an enhanced 
potentiation of the pressor response to PNS in the
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preparation from the hypertensive rat compared to the 
normotensive rats.
Isoprenaline produced a dose-dependent inhibition of the 
pressor response to infusions of exogenous NA in all 
preparations. The magnitude of this inhibition was the 
same in the preparations from the hypertensive and 
normotensive animals i.e. no difference in the degree of 
inhibition of the pressor response to exogenous NA between 
the mesenteric vasculature, or the kidney vasculature, of 
the hypertensive rats and their respective normotensive 
rats.
The facilitatory effect of isoprenaline on the pressor 
response to PNS was markedly reduced by either the non- 
selective £-adrenoreceptor antagonist, propranolol, or the 
selective J^-adrenoreceptor antagonist, ICI 118,551.
The selective p^-adrenoreceptor antagonist, atenolol, did 
not inhibit the isoprenaline induced potentiation of the 
pressor response to PNS in any of the preparations from 
any of the animals. However, atenolol further potentiated 
the isoprenaline-induced potentiation of the pressor 
response to PNS in the preparations from the male SH rat. 
The isolated kidney preparation from the male SH rat 
tended to exhibit this further potentiation, but this 
effect was only statistically significant in the 
mesenteric vasculature of the male SH rat.
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Atenolol, ICI 118,551 and propranolol all reversed the 
isoprenaline induced inhibition of the pressor response to 
exogenous NA. This suggests that the isoprenaline induced 
inhibition of the vasoconstrictor response to exogenous NA 
could be due to physiological antagonism at postsynaptic 
receptor sites. It therefore appears that the inhibitory 
effect of isoprenaline on the pressor response to PNS in 
the preparations from Wistar and NZN rats probably 
resulted from the dominant postsynaptic action of 
isoprenaline (vascular relaxation) masking its presynaptic 
effects (facilitating NA release, thereby enhancing 
vasoconstriction). These findings indicate that the 
dilatation of the mesenteric and kidney vasculature may be 
mediated through the activation of anc* £ 2 ”
adrenore.ceptors. This could therefore explain the 
enhancing effect of atenolol on the isoprenaline induced 
potentiation of the pressor response to PNS in the 
preparations from male SH rats; the enhancement was 
probably due to prevention of the J^-adrenoreceptor 
mediated physiological antagonism of OL-adrenoreceptor- 
mediated vasoconstriction produced by neurally-released 
NA.
Previous reports suggest that the sympathetic adrenergic 
nerve activity may be elevated in the SH rat (Iriuchijima, 
1973; Hallbeck and Folkow, 1974; Judy et al, 1976). In 
the present study, the neurogenic vasoconstrictor response 
was greater in the SH and NZH rats than in the Wistar and 
NZN rats. This finding also lends support to the findings
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of Kawasaki et al (Kawasaki et al, 1984), The 
observations in this thesis suggest that enhanced release 
of NA from vascular adrenergic nerves in response to nerve 
stimulation may contribute to the enhanced adrenergic 
vasoconstriction that is suggested to be present in the SH 
and NZH rat. Since there is also a significant 
enhancement of the response to NA in the vascular 
preparations from SH and NZH rats, the degree of the 
contribution of increased release of NA cannot be assessed 
in the control response.
Some workers have reported a diminished relaxant response 
to isoprenaline in the isolated thoracic aorta from the SH 
rat compared to the Wistar-Kyoto rat (Triner et al, 1975; 
Cohen and Berkowitz, 1976) and have suggested that the 
marked difference of facilitatory effect of isoprenaline 
between the hypertensive and normotensive rats could be 
due in part to the diminished relaxant effect of 
isoprenaline in the SH rat. However, the results 
presented in this thesis show that there is no significant 
difference between the inhibitory effect of isoprenaline 
on the pressor response to exogenous NA in the 
preparations from the respective strains of rats. 
Therefore it is unlikely that the postsynaptic action of 
isoprenaline contributes to the enhanced facilitatory 
effect of the neurogenic pressor response in the 
preparations from SH and NZH rats compared to Wistar and 
NZN rats.
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Thus far the results indicate that physiological 
mechanisms facilitating sympathetic neurotransmission in 
vascular beds are enhanced in the hypertensive rats 
compared to the respective normotensive rats. That the 
facilitatory mechanisms are located presynaptically can be 
inferred from the comparison of the effects of 
isoprenaline on the pressor responses to PNS and NA 
infusion; there is a very clear enhancement of the pressor 
response to PNS by isoprenaline in the SH and NZH rats, 
but no difference in the dose dependent inhibition of 
pressor responses to exogenous NA by isoprenaline in any 
of the preparations from hypertensive and normotensive 
rats. It can further be concluded that the augmentation 
of presynaptic activity by isoprenaline is mediated via 
^ 2 "a(irenoreceptors, since the effect was convincingly 
abolished by a non-selective p-adrenoreceptor antagonist, 
propranolol, and a ^2"selective”a<^ renorececPtor 
antagonist, ICI 118,551, but was unaffected by the 
presence of a J^-selective-adrenoreceptor antagonist, 
atenolol.
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7.2. Enhanced presynaptic angiotensin II receptor- 
mediated modulation of vascular adrenergic 
neurotransmission in Spontaneously Hypertensive rats 
and Nev Zealand Hypertensive rats
The results demonstrate that All enhanced the pressor
responses to exogenous NA and to PNS of the mesenteric and 
kidney vascular beds without affecting the basal perfusion 
pressure. The enhancement of the pressor responses to 
either PNS or NA infusion by All was effectively
antagonised by the competitive All receptor antagonist, 
Sar. Sar did not affect the respones to PNS or NA
infusion in the absence of All, therefore suggesting
receptor specificity of All in its potentiating effects.
The degree of the All induced potentiation of the pressor 
response to PNS was not different to that observed to
infusions of NA in the Wistar and NZN rats; however in the 
SH and NZH rats the degree of the All-induced potentiation 
of the pressor response to PNS was found to be greater 
than the degree of the All-induced potentiation of the 
pressor response to NA infusion.
The degree of All-induced potentiation of the pressor 
response to exogenous NA was the same in the hypertensive 
and normotensive rats, whilst the All-induced potentiation 
of the pressor response to PNS was found to be greater in 
the SH and NZH rats compared to that in the Wistar and NZN 
rats. This suggests that the facilitatory effect of All
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may be due to increased release of NA in response to 
sympathetic nerve stimulation, mediated via presynaptic 
All receptors. Previous investigators have shown that All 
potentiates NA release in response to sympathetic nerve 
stimulation in some tissues (Starke, 1971; Duckies, 1980),
Some investigators have proposed that All potentiates 
vasoconstrictor response by interference with neuronal 
uptake of NA (Palaic and Khairallah, 1967; Campbell and 
Jackson, 1979; Jackson and Campbell, 1979). Therefore, 
the effect of All was further studied in the presence of 
cocaine, an inhibitor of neuronal NA uptake. When All was 
perfused simultaneously with cocaine the potentiation of 
the pressor responses to PNS and exogenous NA were higher 
than those when either of the two drugs were perfused 
separately. Thus, it is unlikely that inhibition of 
neuronal uptake by All accounts for this effect. The 
facilitatory effect of the response to exogenous NA by All 
may be due to nonselective postsynaptic sensitization of 
this peptide reported by Day and Moore (Day and Moore, 
1976).
As previously mentioned, the potentiation of neurogenic 
pressor response by All was significantly greater than 
that of the exogenous NA response in the SH and NZH rats, 
thus indicating that the increase in neurogenic pressor 
response is greater than can be accounted for by the 
postsynaptic sensitizing effect of this octapeptide in the 
preparations from SH and NZH rats. A greater facilitation
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of the response to either PNS or NA by All in SH and NZH 
preparations was observed even in the presence of cocaine.
These results strongly suggest that facilitatory 
modulation of neurotransmission, mediated by presynaptic 
All receptors, is enhanced in the mesenteric and renal 
vasculature from SH and NZH rats. It appears that the 
facilitatory effect of All on the neurogenic 
vasoconstrictor response in the preparations from 
genetically hypertensive animals may be due to increased 
transmitter release from sympathetic adrenergic nerve 
endings•
The results thus indicate that in addition to enhanced 
presynaptic £ 2 “adrenoreceptor-mediated modulation of 
sympathetic neurotransmission in the vascular beds of 
hypertensive animals there is also an enhanced presynaptic 
All receptor-mediated modulation of the sympathetic 
neurotransmission. That the All receptor mediated 
facilitatory mechanism is located presynaptically can be
inferred from the effects of All ' ^n ^erred from the
! ___
effects of All on the pressor responses to PNS and exogenous NA. 
This All-mediated facilitation of adrenergic neurotransmission in 
vascular beds was enhanced in the SH and NZH rats compared to the 
Wistar and NZN rats and was equally marked in the male and female 
SH rats.
Finally, the absence of effect on basal tone of any of the 
antagonists strongly suggests a lack of endogenous agonists 
mediating any significant degeree of tone in these isolated 
preparations.
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7.3 Interaction between presynaptic All receptor and
presynaptic f^-adrenoreceptor *-n t*ie modulation of 
adrenergic neurotransmission in the Spontaneously 
Hypertensive rat and New Zealand Hypertensive rat
The results demonstrate that presynaptic mechanisms that 
facilitate vascular sympathetic neurotransmission involve 
both ^2"a^renoreceP tors anc* All receptors. The results 
also suggest how these two mechanisms may interact with 
one another.
The isoprenaline-induced enhancement of the pressor 
response • to PNS was effectively inhibited by Sar in
preparations from all the strains of rats. This 
inhibition was more marked in the SH and NZH rats than in 
the Wistar and NZN rats (since the isoprenaline-induced 
potentiation of the pressor response to PNS was markedly 
enhanced in the hypertensive rats compared to the 
normotensive rats). The angiotensin II receptor
antagonist did not affect the isoprenaline — induced 
inhibition of the pressor response to NA infusion in the
preparations from any of the rats. This finding led to
the possibility that the facilitatory effect of 
presynaptic j*2 “adrenoreceptors on vascular adrenergic 
neurotransmission was linked to the presynaptic All
receptor in the vascular beds of the rats. Indeed, all 
the components necessary for All synthesis are present in 
the wall of blood vessels (Desjardins-Giasson et al, 1981; 
Dengler, 1956; Dzau, 1984; Luting et al, 1981; Velletri and
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Bean 1982). Captopril, an angiotensin converting enzyme 
inhibitor , effectively inhibited the isoprenaline-induced 
potentiation of the pressor response to PNS in 
preparations from all types of rat without affecting the 
isoprenaline-induced inhibition of the pressor response to 
exogenous NA. Once again, the inhibition of the 
isoprenaline-induced potentiation of the PNS pressor 
response was more marked in the SH and NZH rats than in 
the Wistar and NZN rats.
IGI 118,551 did not affect the All-induced potentiation of 
the pressor responses to PNS and NA infusion in any of the 
preparations from any of the animals.
There have been reports that captopril causes non-specific 
depression of the vascular response to NA in isolated 
blood vessels (Okuno et al, 1979; Kikta and Fregly, 1982), 
however this did not seem to be the case in this study. 
In the previously reported studies the concentrations of 
captopril employed were in the order of 10“5m  to 10"^M, ICI
118,551 did not affect what is assumed to be the
postsynaptically-mediated potentiation by All of the
pressor response to NA.
It appears then that locally generated All, resulting from 
presynaptic P2“ac^ renoreceP tor stimulation contributes to 
the greater enhancement of neurogenic response by
isoprenaline in the SH and NZH rats compared to the
normotensive Wistar and NZN rats.
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7m4. Goldblatt, two-kidney, one-clip renal hypertension: 
Involvement of facilitatory presynaptic receptors
The results described in this thesis show that the two- 
kidney, one-clip procedure was effective in inducing 
hypertension in the Wistar rat. This procedure also 
caused an enhanced vasoconstrictor response to PNS and 
exogenous NA in the isolated mesenteric vasculature. This 
increased responsiveness to PNS and to exogenous NA could 
indicate an increased vascular tone in the renal 
hypertensive rats and might further suggest that this 
increased tone could contribute to the hypertension in 
this experimental model.
Since enhancement of presynaptic ^2"a<^ renoreceP tor" 
mediated and presynaptic angiotensin II-receptor-mediated 
facilitation of adrenergic neurotransmission in the 
vascular beds of hypertensive rats has been shown 
previously, the possibility of these two presynaptic 
facilitatory mechanisms being enhanced in the Goldblatt, 
two-kidney, one-clip renal hypertensive rat was 
investigated. Indeed, the results presented in this 
thesis show that the physiological mechanisms facilitating 
sympathetic neurotransmission in the mesenteric vascular 
bed are enhanced in the renal hypertensive rats compared 
to the normotensive Wistar rats. That the facilitatory 
mechanisms are located presynaptically can be deduced from 
the comparison of the effects of isoprenaline and 
angiotensin II on the pressor response to PNS and NA
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infusion. It can be further concluded that the 
augmentation of presynaptic activity by isoprenaline is 
mediated via ^ “adrenoreceptors and that of angiotensin II 
via pre-synaptic angiotensin II receptors.
It follows from these deductions that if the concept of 
presynaptic £ 2 “ac*renoreceptor-mediated facilitation of 
adrenergic neurotransmission is accepted then antagonism 
of the presynaptic P2“a<^ renoreceP tor would attenuate, at 
least to some degree, this facilitatory mechanism. In the 
isolated mesenteric vascular preparation from renal 
hypertensive rats treated chronically with ICI 118,551 the 
isoprenaline-induced potentiation of the pressor response 
to PNS was completely abolished compared to that of the 
untreated renal hypertensive rat. Chronic treatment with 
ICI 118,551 did not affect the isoprenaline-induced 
inhibition of the pressor response to NA infusion compared 
to that in the untreated renal hypertensive rats. Indeed, 
the progression of the hypertension in the Goldblatt, two- 
kidney, one-clip renal hypertensive rats was significantly 
attenuated by chronic administration of ICI 118,551. 
However, chronic treatment of the renal hypertensive rats 
with ICI 118,551 did not completely abolish the rise in 
systolic blood pressure. This inability of ICI 118,551 to 
completely arrest the rise in systolic blood pressure in 
the renal hypertensive rats could be attributed to other 
mechanisms contributing to the hypertension rather than 
the sole involvement of the presynaptic ^2“a<^ renorecePl°r • 
One of these other mechanisms contributing to the
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hypertension could well be the renin-angiotensin system. 
In the preparations from renal hypertensive rats, and even 
from renal hypertensive rats treated chronically with ICI 
118,551, the angiotensin II-induced potentiation of the 
pressor responses to PNS and exogenous NA were 
significantly enhanced compared to the normotensive 
control Wistar rats.
The pressor response to exogenous NA in the preparations 
from renal hypertensive rats treated chronically with ICI
118,551 did not differ from that in the untreated renal 
hypertensive rats. However, the pressor response to PNS 
in the preparations from renal hypertensive rats treated 
chronically with ICI 118,551 was significantly lower than 
that in the untreated renal hypertensive rats. This 
indicates that chronic treatment with ICI 118,551 
affected neural release of NA since postsynaptic responses 
to NA infusion were not different in the preparations from 
each group.
One of the possible ways that ICI 118,551 could attenuate 
the release of neural NA is by blockade of the 
facilitatory presynaptic J^-adrenoreceptor. Chronic
treatment with ICI 118,551 probably antagonizes the 
presynaptic j$2 “adrenoreceptor during the progression of 
the hypertension in the two-kidney, one-clip renal 
hypertensive rats. However, from the studies in the 
isolated perfused mesenteric vascular preparations it 
seems that chronic treatment of the renal hypertensive
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rats with ICI 118,551 completely abolished the presynaptic 
B 2 -adrenoreceptor-mediated facilitation of adrenergic 
neurotransmission in the preparations. This could be 
because the chronic treatment with ICI 118,551 had a 
direct effect on the presynaptic B 2 ~adrenoreceptors by 
"deactivating" them; hence perfusion of B-adrenoreceptor 
agonists in the tissue from rats chronically treated with 
ICI 118,551 would not have any affect on the pressor 
response to PNS.
Alternatively, chronic treatment with ICI 118,551 could 
directly attenuate the turnover of NA in the 
postganglionic nerve endings. However in the work carried 
out by Bilski et al (1983), ICI 118,551 did not affect the 
heart rate in beagle dogs thereby indicating that ICI
118,551 did not affect NA turnover.
It has been reported that ICI 118,551 has membrane- 
stabilizing potency similar to that of propranolol (Bilski 
et al, 1983), and that this membrane-stabilizing effect 
could attenuate the PNS-induced release of NA from the 
nerve endings; however, if the membrane-stabilizing effect 
of ICI 118,551 was responsible for the decreased pressor 
response to PNS then the vasoconstrictor response to PNS 
in the preparations from normotensive control rats would 
be attenuated when ICI 118,551 was perfused through them 
compared to the PNS response when physiological saline 
(Krebs solution) was perfused through them. Therefore 
this reason too seems improbable. It therefore seems then
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that ICI 118,551 reduces the pressor response to PNS via 
antogonism of presynaptic J^-^renoreceptors i-n t i^e 
mesenteric vasculature and that the decreased 
vasoconstriction leads to a decreased peripheral 
resistance and therefore to a decreased blood pressure. 
It remains to be seen whether this effect of ICI 118, 551 
is true for other vascular preparations besides the 
mesenteric vascular bed.
It has been demonstrated that plasma renin activity is 
elevated in the two-kidney, one-clip model of hypertension 
(Horovitz, 1981; Sweet et al, 1984; Laffan et al, 1978; 
Iso et al, 1981) and this would imply that circulating 
plasma levels of angiotensin II would be elevated in the 
renal hypertensive models compared to that in normotensive 
animals. Due to the nonselective postsynaptic
sensitization to NA by All (Day and Moore, 1976), which 
has also been demonstrated in this thesis, the increased 
vasoconstrictor effect of NA on postsynaptic tissue would 
contribute to the increased vascular tone and therefore 
the increased blood pressure in the renal hypertensive 
rats compared to normotensive control rats. Coupled to 
this, the increased concentration of circulating 
angiotensin II in the renal hypertensive rats could 
activate presynaptic All receptors thereby releasing 
increased amounts of NA into the general circulation in 
response to nerve impulses and therefore contributing to 
the overall increase in vascular resistance and increasing 
blood pressure. Indeed, the basal perfusion pressure of
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the preparations from renal hypertensive rats has been 
demonstrated to be higher than that in the normotensive 
rats. The results show that in the preparations from 
renal hypertensive rats treated chronically with ICI
118,551 and from untreated renal hypertensive rats the 
presynaptic angiotensin II-receptor-mediated facilitation 
of adrenergic neurotransmission is enhanced compared to 
that in normotensive control rats.
The plasma levels of Ad and NA in the renal hypertensive 
rats were significantly higher than those in the renal 
hypertensive rats treated chronically with ICI 118,551 and 
both these types of rats had significantly elevated levels 
of plasma Ad and NA compared to the Wistar rats. The
results from the experiments involving preparations from 
renal hypertensive rats indicate that the sympatho-adrenal 
medullary activity may be increased and that the adrenal 
medulla may contribute to the progression of the
hypertension in this model.
However, Finch and Leach (1970) have shown that
experimental hypertension in the rat is independent of the 
adrenal medulla provided an adequate salt intake is
maintained. However, the results in this thesis indicate 
that there may be some, contribution of the adrenal 
medulla in the maintenance of the hypertension in the two- 
kidney, one-clip model of renal hypertension since plasma 
Ad levels in the renal hypertensive rats were elevated 
compared to control Wistar rats; also chronic treatment
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with ICI 118,551 may have antagonised the action of 
adrenaline at the presynaptic £ 2 "ac*renoreceptors thereby 
attenuating the progression of the blood pressure in this 
model of renal hypertension. There has been evidence that 
there is an elevation of plasma renin activity and 
elevated concentration of renin in the arterial walls of 
experimental renal hypertension (Garst et al, 1979).
Furthermore, Garst et al (1979) have shown that as the 
renal hypertension becomes chronic, the concentration of 
renin in the arterial wall remains elevated as the plasma 
renin activity is reduced to normal or sub-normal levels. 
Thus, the increased arterial wall renin is associated with 
the elevated blood pressure in the acute stage of renal 
hypertension, and increased renin content may well
continue to maintain the hypertension in the chronic stage
despite the fall in plasma renin at this stage (Garst et 
al, 1979). These results lend supoport to the findings of 
this thesis that the presynaptic angiotensin II receptors 
are enhanced in the isolated mesenteric vascular 
preparations from renal hypertensive rats and this
indicates an enhanced vascular renin-angiotensin system in 
the mesenteric vascular beds of renal hypertensive rats.
Thus the results indicate that in the Goldblatt, two- 
kidney, one-clip renal hypertensive rat, the development
and maintenance of the hypertension is partly dependent on 
the presynaptic £ 2 -adrenoreceptor-mediated facilitation of 
neurogenic pressor response and probably more dependent on 
a local renin-angiotensin system present in the arterial
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walls of the vasculature, the effects of which are 
mediated via presynaptic angiotensin II-receptors which 
facilitate adrenergic neurotransmission in the vasculature.
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7.5 Oestrogen-induced hypertension: Involvement of
presynaptic P^-adrenoreceptors
The results demonstrate that there is a decrease of body 
weight of rats treated chronically with EO compared to the 
non-treated rats. It is suggested that the decrease in
body weight after chronic EO adminstration may be due to
either (i) anoretic and/or (ii) antiandrogenic actions of 
EO (Meites, 1949; Glesser, 1954). The decrease in body 
weight was significantly greater in the male rats treated 
with EO than in the female rats similary treated.  ^ The 
blood pressure of rats chronically treated with EO was 
elevated compared to the normotensive untreated rats.
This elevation was significantly higher in the female rats 
than in the male rats, confirming the findings of Bhatt et 
al (Bhatt and Gulati, 1986). This sex-related difference 
could be due to the presence of androgenic hormones in the 
male rats which might tend to inhibit the peripheral 
vascular actions of catecholamines and neurohypophyseal 
hormones (Altura, 1973; Greenberg et al, 1973).
In addition, it has been reported that mesenteric
arterioles of female rats are more sensitive than those of 
males to vasoconstrictor action of catecholamines and 
neurohypophyseal hormones (Altura, 1975). However, in 
this study the results show that there was no significant 
difference between the male and female rats treated with 
EO in their responses to PNS and NA infusions in the 
mesenteric and renal vasculature.
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The pressor responses to PNS and NA infusion in the 
preparations from rats treated chronically with EO were 
enhanced compared to the untreated rats. The enhanced 
responsiveness to NA infusion in the EO-treated rats could 
be explained by alteration in the structural component of 
the resistence vessels (McGregor and Smirk, 1970; Folkow 
and Hallbeck, 1977) and an increase in the number of OC- 
adrenoreceptors. After oestrogen treatment increase in 
the number of oC-adrenoreceptors has been demonstrated in 
extravascular smooth muscles, without change in their 
affinity (William and Lefkowitz, 1977; Rand et al, 1977). 
However, Colucci et al (1982) using a radioligand 
technique, proposed that oestrogen-induced increase in 
sensitivity to catecholamines of the mesenteric vascular 
bed may be partly mediated through an increase in oC“
adrenoreceptor affinity. In the present study no attempt 
was made to study affinity of the receptors in vascular
bed to NA or the increase of oC-adrenoreceptors.
The role of the adrenal medulla in rats made hypertensive 
with androgen treatment (DeChamplain, 1977) and with 
oestrogen treatment (Bhatt et al, 1986) has been 
implicated previously. Indeed, significant increases in 
dopamine-p-hydroxylase (DBH) activity in the adrenal 
glands of EO-treated animals have been reported (Bhatt et 
al, 1986). It seems possible that the increase in DBH
activity in adrenal medulla after chronic EO treatment may 
increase the synthesis of catecholamines and subsequently 
lead to release of more catecholamines in the general
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circulation producing elevation in blood pressure. 
Increases in NA levels in hypothalamic regions and in the 
adrenal medulla have been previously reported (Lew, 1982) 
after higher doses of mestranol, whereas decreases have 
been described in young rats receiving lower doses of 
mestranol (Lew, 1975; 1978).
In the work described by Bhatt and Gulati (1986), the 
increase in weight of the adrenal glands from EO-treated 
rats compared to untreated rats could be attributed to the 
hypertrophic appearance of the gland which in turn could 
be caused by increased DBH activity in the adrenal glands. 
The results presented in this thesis also lend support to 
these findings in that I found that the weights of adrenal 
glands from rats treated chronically with EO are greater 
than those from untreated normotensive rats.
In addition to the above possibility for the increased 
blood pressure and increased response to NA infusions in 
rats treated chronically with EO, another suggestion may 
be advanced and that is the involvement of the presynaptic 
^ 2 "adrenoreceptor and the presynaptic angiotensin II 
receptor which have been previously identified in the SH 
and NZH rats.
The results described in Chapter 5 show an enhanced 
isoprenaline-induced potentiation of the pressor response 
to PNS in the preparations from rats treated chronically 
with EO compared to those from untreated normotensive
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rats. There were no differences in this enhancement 
between the equivalent preparations from male and female 
rats. Isoprenaline caused an inhibition of the pressor 
reponse to NA infusion in all the preparations. The 
degree of this inhibition was the same in the preparations 
from the oestrogen-induced hypertensive rats and 
normotensive rats, indicating that the mechanisms of 
vasodilatation in the vascular beds from the oestrogen- 
induced hypertensive rats and normotensive rats are not 
dissimilar. Isoprenaline alone had no effect on the basal 
perfusion pressure of any of the preparations.
The facilitatory effect of isoprenaline on the pressor 
response to PNS was markedly reduced by ICI 118,551 in all 
the preparations. Atenolol did not inhibit the
isoprenaline induced potentiation of the pressor response 
to PNS in any of the preparations. Neither ICI 118,551 
nor atenolol had any effect on the basal perfusion 
pressure or the pressor response to PNS in any of the 
preparations. However, atenolol and ICI 118,551
effectively reversed the isoprenaline induced inhibition 
of the pressor response to NA infusion in preparations 
from all of the animals.
All caused a potentiation of the pressor response to PNS 
in all the preparations. This potentiation was of a 
similar magnitude in the oestrogen-induced hypertensive 
rats and normotensive rats. All also caused a
potentiation of the pressor response to exogenous NA in
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all the preparations. Once again, this potentiation was 
of a similar magnitude in the oestrogen-induced 
hypertensive rats and the normotensive rats. The results 
from experiments involving All therefore show that in the 
vasculature from animals chronically treated with EO the 
presynaptic All receptor mediated modulation of adrenergic 
neurotransmission is not dissimilar to that in the 
normotensive rats i.e. it is not enhanced as found in the 
SH, NZH and renal hypertensive rats.
Neither captopril nor Sar had any effect on the basal 
perfusion pressure or the pressor responses to PNS and 
exogenous NA in any of the preparations, however they both 
inhibited the isoprenaline-induced potentiation of the 
pressor response to PNS in all the preparations. Neither 
captopril nor Sar had any effect on the isoprenaline 
induced inhibition of the pressor response to exogenous NA 
in any of the preparations.
The results indicate that local generation of All is 
required for the enhancement of adrenergic 
neurotransmission in the vasculature of EO-treated rats 
via presynaptic P 2 "a<^ renorecePtors since both captopril 
and Sar effectively inhibited the isoprenaline-induced 
potentiation of the PNS pressor response in those tissues. 
The sequence of events in the facilitation of adrenergic 
neurotransmission in the vasculature from oestrogen- 
induced hypertensive rats is probably the activiation of 
presynaptic ^2“a<^ renoreceP tors which could activate a
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vascular renin-angiotensin system to generate All locally. 
All produced this way then causes a modest enhancement of 
the pressor response to PNS.
It therefore appears that the presynaptic £ 2 “ 
adrenoreceptor facilitatory mechanism is enhanced in the 
vasculature from oestrogen-induced hypertensive rats 
compared to normotensive rats. This enhanced facilitatory 
effect is qualitatively and quantitatively similar in the 
preparations from male and female rats chronically treated 
with EO.
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7.6 Plasma adrenaline and noradrenaline levels
The method of collecting blood samples from rats for 
plasma catecholamine analysis affects the determination of 
the catecholamine concentration in the blood samples.
McCarty et al (1978) have previously shown that the plasma 
NA and Ad levels in the SH and Wistar-Kyoto rats vary when 
the blood samples are collected in the undisturbed, mildly 
disturbed and shocked rats. Decapitation of rats in order 
to collect blood samples increases the plasma Ad and NA 
levels (Popper et al, 1977).
The method used for the collection of the blood samples in 
this thesis involved placing the animal in a bell-jar and 
inducing anaesthesia with ether. This procedure tended to 
cause a degree of stress in the animal, however, the 
procedure was the same for all the rats used in this 
study.
The results show that the plasma Ad and NA levels in the 
SH rats are elevated compared to those from Wistar rats. 
The elevation is significant in the SH rats from the age
of three weeks onwards. No difference in the plasma
\
catecholamine levels between the males and females of each 
strain of rats was observed. A rapid increase in plasma 
NA and Ad levels in the SH rats was observed between the 
ages of three to twelve weeks. An elevated plasma NA 
level in SH rats has been noted only during the
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prehypertensive state (Yamori, 1974; Grobecker et al, 
1975) and not during the maintenance stage (Yamori, 1974). 
On the other hand , Vlachakis et al (1980) reported an 
increased plasma concentration of normetanephrine in SH 
rats. Normetanephrine is an extraneuronal metabolic 
product of NA and provides a useful index of sympathetic 
function (Vlachakis et al, 1980).
Plasma NA and Ad levels in the two-kidney, one-clip renal 
hypertensive rats were found to be significantly elevated 
compared to those from age-and-sex matched SH and Wistar 
rats. The plasma catecholamine levels in the renal 
hypertensive rats chronically treated with ICI 118,551 
were not different to those from age-and-sex-matched SH 
rats but significantly higher and lower than those from 
age-and-sex-matched Wistar and untreated renal 
hypertensive rats respectively.
The plasma NA and Ad levels in the Wistar rats chronically 
treated with EO were elevated compared to those from the 
normotensive Wistar rats. Howevever, this elevation was 
significantly less than that found in the SH rats. The 
hypertrophic nature and increase in weight of the adrenal 
glands observed could be related to the increase in 
dopamine-^-hydroxylase activity in the gland previously 
reported (Bhatt et al, 1986).
There is an indication that plasma levels of Ad in the 
female rats treated chronically with EO are slightly
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elevated compared to those from male rats similarly 
treated. This could probably explain the higher systolic 
blood pressure in the female EO treated rats than in the 
male EO treated rats.
It therefore seems that sympatho-adrenal activity plays an 
important role in the maintenance and persistence of the 
three forms of hypertension described in this thesis. 
Indeed, an increase in the SH rat of the adrenal medullary 
activity of the rate-limiting enzyme for catecholamine 
biosynthesis, tyrosine hydroxylase, has been reported in 
utero (Teitelman et al, 1981) and in the adult SH rat 
(Grobecker et al, 1982). The Ad and NA content of the 
adrenal medulla of the SH rat has also been reported 




The results described in this thesis indicate that 
presynaptic £ 2 “adrenoreceptor-mediated facilitation of the 
neurogenic pressor response in vascular tissues of 
hypertensive rats is enhanced compared to that of 
normotensive control rats. This facilitatory mechanism is 
qualitatively and quantitatively similar in male and 
female rats irrespective of whether the hypertension was 
experimentally induced or genetically inherent. In all 
the hypertensive models, except that of the oestrogen- 
induced hypertension, there also exists an enhanced 
presynaptic All-receptor-mediated facilitation of the 
neurogenic pressor response in the vasculature.
This facilitatory mechanism is qualitatively and 
quantitatively similar in male and female SH, NZH and 
renal hypertensive rats. The results obtained in this 
thesis imply that an enhanced local renin-angiotensin 
system exists in the arterial walls of SH, NZH and renal 
hypertensive animals and that this system, coupled with 
that of the presynaptic P2“ac^ renoreceP tor> contributes to 
the development and/or maintenance of hypertension.
Previous reports have indicated that the renin-angiotensin 
pressor system does not participate in the maintenance of 
hypertension in the SH rats (Sokabe, 1965; Koletsky et al, 
1970) and that the hypertensive state is maintained by an 
increase in neurogenic vasoconstrictor influences (Nosaka
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et al, 1972; Okamoto et al, 1967; Yamori et al, 1969) 
which could theoretically be associated with an increase 
in the turnover of catecholamines (Molinoff et al, 1971). 
However, a number of reports indicate a decrease in 
catecholamine turnover in peripheral tissue from SH rats 
(Nakamura et al, 1971; Yamori et al, 1972). Other workers 
have suggested that structural changes of blood vessels 
may be involved in the maintenance of the hypertensive 
state in the SH rat (Folkow et al, 1972; Mulvany, 1984). 
According to this suggestion, increased media/lumen ratio 
causes a high basal vascular resistance and changes in the 
responsiveness to vasoconstrictor stimuli.
SH rats are of interest to experimentalists and clinicians 
as they provide close facsimiles of essential hypertension 
in humans (Grollman, 1972), therefore it is desirable to 
define more clearly what causes and maintains the 
hypertension in the SH rat.
The components of two facilitatory mechanisms mentioned 
above are therefore present in the normotensive rats but 
the mechanisms are not "activated" or enhanced as in the 
SH and NZH rats. Results from the experiments involving 
the two-kidney, one-clip renal hypertensive rats indicate 
that the occlusion of the renal artery causes an increase 
in the blood pressure of the animals, possibly due to an 
increased sympatho adrenal activty (Asaad et al, 1982) and 
an increased plasma and arterial wall renin activity 
(Garst et al, 1979). Indeed in the preparations from
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renal hypertensive rats the presynaptic p2"a^renoreceP tor“ 
mediated facilitation of neurogenic pressor response was 
enhanced compared to that in normotensive control animals. 
In addition, presynaptic All-receptor-mediated
facilitation of the neurogenic pressor response also 
appeared to be enhanced in this model of hypertension. 
Chronic treatment of renal hypertensive rats with ICI
118,551 significantly reduced the development of the 
hypertension and antagonised the isoprenaline-induced 
potentiation of the PNS pressor response in the isolated 
mesenteric vasculature, thus indicating that the 
presynaptic ^2“a<3renoreceptor-mediated facilitation of the 
neurogenic pressor response partly contributed to the 
maintenance of the hypertension in the renal hypertensive 
rat. In support of this, plasma Ad levels in the renal 
hypertensive rats were found to be elevated compared to 
those in the normotensive Wistar rats. The plasma Ad and 
NA levels in the renal hypertensive rat treated 
chronically with ICI 118,551 were similar to those in the 
SH rats and the levels of the catecholamines in these two 
models were lower than those in the untreated renal 
hypertensive rat.
The results from the experiments involving preparations 
from rats treated chronically with EO show that 
presynaptic j^-adrenoreceptor-mediated facilitation of 
adrenergic neurotransmission is enhanced in these 
preparations compared to those from normotensive Wistar 
rats. The plasma levels of Ad, and NA also, were elevated
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in the EO-treated rats compared to those in the 
normotensive rats. No enhancement of the facilitatory 
presynaptic All-receptor-mediated activity was observed in 
the preparations from EO-treated rats compared to those 
from normotensive rats. The adrenal glands from EO- 
treated rats were heavier and appeared to be hypertrophic 
in nature compared to those from normotensive rats. Thus 
this indicates that sympatho-adrenal mediated activity was 
the main contributor to this form of hypertension.
The possibility that the chronic treatment with EO did not 
elevate the systolic blood pressure of the rats to as a 
high degree as that caused by renal artery occlusion could 
be attributed to an enhanced presynaptic alpha 
adrenoreceptor-mediated inhibition of the pressor response 
to PNS. There have been reports of oestrogens increasing 
the affinity of Cl-adrenoreceptors in blood vessels of rats 
(Colucci et al, 1982) and in the uterus of rabbits
(Hoffman et al, 1982). Thus it could be that in the rats 
treated chronically with EO the oestrogen could have 
increased the sensitivity of the presynaptic 
alpha -adrenoreceptor thereby attenuating the increase in 
systolic blood pressure thought to be mediated via
facilitatory presynaptic ^ 2 “adrenoreceptors.
However, though the increased contribution of the
sympatho-adrenal activity is implied in this form of
hypertension, both captopril and Sar effectively inhibited 
the isoprenaline-induced potentiation of the pressor 
response to PNS in the preparations from EO-treated rats.
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Thus the results described in this thesis show that the 
effects mediated via facilitatory presynaptic £ 2 “ 
adrenoreceptors are linked to a local renin-angiotensin 
system and that it is All, or an All-like substance, that 
finally facilitates adrenergic neurotransmission in 
vascular preparations from hypertensive rats. The 
evidence from the two experimental models of hypertension 
could give some insight as to the development and/or 
maintenance of hypertension in the genetically 
hypertensive rats. The facilitatory effects of
presynaptic P2”a^renoreceP tors are invariably mediated 
finally via angiotensin II, or All-like product, in all of 
the hypertensive models in this study. That the 
presynaptic All-receptor-mediated facilitatory mechanism 
is enhanced in all the hypertensive models described in 
this study (except that of rats made hypertensive by 
chronic treatment with EO) indicates that the two 
facilitatory mechanisms are interdependant. Though these 
two facilitatory mechanisms are inter-related, either of 
them could be independently activated to facilitate 
adrenergic neurotransmission in vascular tissue.
It seems that experimentally-induced hypertension causes 
increased amounts of catecholamines, and probably All, in 
the plasma.. The surge of these chemicals could alter the 
affinity and/or the number of presynaptic £ 2 “ 
adrenoreceptors and presynaptic All receptors.
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Blaustein (Blaustein, 1985) suggests that a sodium-pump 
inhibitor, natriuretic hormone, promotes natriuresis 
whilst at the same time increasing peripheral vascular 
resistance through a direct action on vascular smooth 
muscle. A functional (genetic or acquired) defect in 
renal excretion (undetectable by standard renal function 
tests) can, in the presence of an excessive salt load, 
lead to the development of hypertension. The initial 
tendency toward salt and water retention and extra 
cellular fluid volume expansion is compensated by the 
secretion of a natriuretic hormone that promotes Na 
excretion by inhibiting Na pumps in renal tubule cells. 
This hormone could also inhibit the Na pump in other types 
of cells, including vascular smooth muscle cells. Then, 
because the vascular smooth muscle cells contain Na/Ca 
exchange transport mechanisms in their plasma membranes, 
more Ca than normal would be delivered to these cells. 
This could therefore cause the increased contractility and 
reactivity associated with increased vascular tone and 
peripheral vascular resistance.
This inhibition of the Na pump could amplify the effects 
of adrenergic agents, and other humoral agents, on the 
vascular smooth muscle cells thereby enhancing adrenergic 
neurotransmission in the vascular beds of the 
preparations. This thus indicates that the sensitivity 
rather than possibly the increase in number of presynaptic 
facilitatory mechanisms may be increased in the 
hypertensive rat than in the normotensive rat.
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The experimental hypertension could, for instance, release 
one or more substances which in turn sensitizes the 
presynaptic facilitatory mechanisms thereby causing the 
mechanism to actively maintain the hypertensive state. 
Work done previously (McMurtry et al, 1981) has shown that 
an animal genetically programmed to be normotensive can 
become hypertensive if it is nursed by a hypertensive 
mother. Some factor, probably a cerebrohypothalamic 
neurotransmitter, may be transmitted through the milk, 
triggering the pathogenesis of progressively increasing 
blood pressure. It appears that this factor is specific 
in genetic transcription since not all genetically 
normotensive weanlings nursed by hypertensive dams 
responded by developing hypertension (McMurtry et al, 
1981).
This factor, a hypertensinogen, that will induce high 
blood pressure de novo, has been sought in hypertensive 
humans (Sen et al, 1977). Although this factor causes 
increased aldosterone-secretion, sodium retention, blood 
volume expansion, and sustained hypertension - all reduced 
by adrenalectomy - it is not adrenocorticotrophic hormone, 
renin, or angiotensin (McMurtry et al, 1981; Sen, 1977). 
It has been shown (Sen et al, 1977) that a compound has 
been isolated from normal human urine and it contains a 
protein fraction that interacts with the adrenal cortex 
and induces hypertension in rats that is characterized by 
volume expansion, suppressed renin activity, and marked 
increases in plasma aldosterone. It is probable that such
239
a compound may be transmitted from the mothers milk and 
trigger the pathogenesis of hypertension in the rat.
In addition to the possible involvement of cerebropeptides 
in the triggering of hypertension, a second messenger may 
be involved. This second messenger could come from the 
adrenal glands since adrenalectomised rats reduce the 
effects of the hypertensinogen (probably a 
cerebrohypothalamic neuropeptide). A possible second 
messenger could be the polypeptide, natriuretic hormone, 
the role of which has been discussed above.
It may well be that chronic treatment with EO and ICI
118,551 has central actions in the rat, and that these two 
chemicals alter the state of the hypertension. For 
example, it has been shown that long term administration 
of EO caused a significant increase in pituitary and 
adrenal gland size in the rat (Leonara and Crane, 1970) 
and that women taking oral contraceptives have an 
increased serum dopamine-p -j.hydroxylase activity (Rockson 
et al, 1975). Propranolol, a non-selective
adrenoreceptor antagonist, has been reported to have a 
central hypotensive effect (Alexander et al, 1975; Garvey 
et al, 1975; Day et al, 1973; Reid et al, 1974).
Conversely, it follows from these examples that 
catecholamines, All and/or other chemicals (probably 
cerebropeptide neurotransmitters) may have a central role 
in the development and/or maintenance of the hypertension.
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Therefore, the increased total vascular resistance 
resulting from enhanced sympathetic adrenergic nerve tone, 
thought to be the cause of the increased blood pressure in 
the SH rat (Iriuchima, 1973; Cheng et al, 1980), could be 
the prime candidate in the role of the development and 
maintenance of the hypertension in the genetically 
hypertensive rat. Indeed, Antonaccio (1985) suggests that 
angiotensin I is converted to All in the intimal layer of 
an artery and that the locally generated All would 
facilitate sympathetic neurotransmission in the medial 
layer of the artery. This suggestion is supported by the 
findings of Mulvany (1984), that the media/lumen ratio of 
resistance vessels in the SH rat is increased. This could 
imply that a greater conversion of angiotensinogen to 
angiotensin II takes place in the resistance vessels. 
Thus the locally generated All could then facilitate 
sympathetic neurotransmission in the medial layer of the 
blood vessel.
Indeed, work done previously indicates that angiotensin- 
converting-enzyme (ACE) inhibitors are effect in lowering 
blood pressure (Nakata et al, 1987; Okuno et al, 1979; 
Kikta et al, 1982) and because of this the ACE inhibitors 
are gaining popularity in their effectiveness as 
antihypertensive agents.
It therefore seems that the development and maintenance of 
the hypertension in the genetic model largely results from 
an increased presynaptic P2"ac^ renoreceP tor mediated
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activation of the vascular renin-angiotensin system 
thereby releasing locally generated All which in turn 
facilitates adrenergic neurotransmission in the 
vasculature
It remains to be seen whether the facilitatory systems and 
other features contributing to the hypertension in genetic 
models are genetically pre-determined, or whether there 
are one or more substances that are released (genetically 
pre-determined) and which alter the normal functioning of 
the haemodynamics in the rat and lead to the features that 
contribute to the hypertension.
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7.8 Clinical implications
Stimulation of presynaptic P2“ac^ rerioreceP tors facilitates 
the release of NA from sympathetic nerve endings. The
hypertensive action of adrenaline infusion in the rat 
(Majewski et al, 1981b) may be explained by such a 
mechanism. It has been shown in man that low-dose
infusion of Ad increases plasma NA (Nezu et al, 1983;
Musgrave et al, 1984; Vincent et al, 1983) and that it
amplifies sympathetic pressor effects (Vincent et al, 
1983). Conversely, by blocking these presynaptic 
adrenoreceptors, blood pressure could be lowered.
Antagonism of the presynaptic B-adrenoreceptor could also 
reduce the amount of locally-generated All being formed 
and therefore lower the blood pressure. Indeed,
ICI 118, 551 does lower blood pressure in man (Vincent et 
al, 1985). The effect of ICI 118,551 could also have been 
mediated by the antagonism of the presynaptic 
B 2 -adrenoreceptors in the juxtaglomerular apparatus 
thereby reducing plasma renin (Vincent et al, 1985). 
However, it is important to note that the blood pressure 
fall in hypertensive man due to administration of 
propranolol or ICI 118,551 does not correlate with renin 
suppression (Vincent et al, 1985). It is probable that 
the antihypertensive effect of ICI 118,551 correlates with 
arterial ACE activity.
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The involvement of tissue ACE suggests the indication of 
using ACE inhibitors in the management of essential 
hypertension. Work done in the SH rat by Nakata et al, 
(1987) show that a good positive correlation exists 
between basal blood pressure and ACE activity in the aorta, 
Nakata et al, (1987) suggest further that the 
antihypertensive action of SA446, an ACE inhibitor, may be 
due to inhibition of arterial ACE activity in addition to 
inhibition of plasma and kidney ACE activity.
Therefore, selective ^ “^renoreceptor antagonists and ACE 
inhibitors with a high selectivity for tissue ACE activity 
probably have important roles in the management of 
essential hypertension in humans.
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7.9 Suggestions for possible future work
The work described in this thesis shows the presence of 
presynaptic receptor-mediated mechanisms facilitating 
adrenergic neurotransmission in the isolated mesenteric 
vascular preparation and in the isolated kidney 
preparation. More research should be carried out, along 
the same lines as in this study, in other isolated 
vascular preparations, for example, the rat caudal artery. 
This would be done in order to see if the findings of this 
thesis are true for other isolated vascular preparations. 
In addition to this, other suggestions are:-
a) Effect of chronic treatment with ACE inhibitors 
in hypertensive rats (genetic and experimental 
models). The effect of the chronic treatment on 
presynaptic receptor-mediated facilitation of 
adrenergic neurotransmission in isolated 
vascular preparations could be looked at #
b) Effect of chronic treatment with selective 
J$2 ~adrenoreceptor antagonists
in hypertensive rats (genetic and 
experimental models). The effect of the 
chronic treatment on the facilitatory 
presynaptic mechanism in isolated vascular 
preparations could also be looked at.
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c) Since a central mechanism is also implicated 
in the development and maintenance of 
hypertension, the central role of adrenaline 
and angiotensin II could be looked at .
d) Effect of hypophysectomy on the progression of 
the blood pressure in genetic models of 
hypertension. The effect of hypophysectomy
on the enhanced presynaptic receptor- 
mediated facilitation of adrenergic 
neurotransmission in isolated vascular 
tissue could be investigated. This could give 
insight to the possibilities of 
cerebrohypothalmic neurotransmitters being 
involved in the induction and/or development 
of hypertension .
e) Following on from "d" the possibility of 
linking cerebropeptide-mediated effects with 
the functioning of the adrenal glands in 
regard to the development of hypertension.
The possibility of a second messenger, 
probably from the adrenal glands, being 
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FAC ILIT ATO R Y  P R E - S Y N A P T I C  R E C E P T O R S  IN THE ISOLATED P E R F U S E D  RAT 
M E S E N T E R Y  ~
A.J. Draper, S.A. Meghj i and P.H. Redfern, Pharmacology Group, School of 
Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY.
It is generally accepted that presynaptic receptors modulate neurotransmitter 
release from sympathetic nerve endings (Starke, 1981). Various neurohumoral 
agents (Angiotensin II and beta-adrenoceptor agonists) have been shown to 
facilitate this release. Demonstration of the existence of a complete renin- 
angiotensin system in the rat mesenteric vascular wall (Desjardlns-Glasson et 
al, 1981) raises the possibility of an involvement of this system in the 
lsoprenaline (Iso)-induced facilitation of adrenergic neurotransmission 
(Kawasaki et al, 1984). Male and female Japanese Spontaneously Hypertensive 
rats (SHR, m and SHR, f, respectively) and New Zealand Hypertensive rats (NZH, 
f) 190-260g were used. The isolated perfused mesentery was set up as described 
by McGregor (McGregor, 1964) and increases in perfusion pressure in response to 
periarterial nerve stimulation (PNS) (80V, 1msec, 30Hz for lOsec) were recorded 
in the presence of a range of concentration of Iso. It was found that in all 
three groups Iso caused a significant dose-dependent potentiation of the pressor 
response to PNS. This potentiation was blocked by ICI 118,551 but not by 
atenolol. Addition of angiotensin II (All), lOng/ml, to the perfusate 
significantly potentiated the pressor response to PNS. This potentiation was 
attenuated by [ Sari- Ile8]angiotensin II (SAR), an All antagonist. The SAR 
itself markedly attenuated the ISO-induced potentiation of the pressor response 
to PNS; however, ICI 118,551 did not affect the All potentiation of the pressor 
response.
TABLE 1
% Perfusion pressure in response to PNS (control 100%)
ISO
(5xlO"8M)
ISO + atenolol 
(10 M)




ISO + SAR 
(200ng/ml)
SHR, m 150+/-4 2 07+/-11. 9S+/-5 158+/-7 104+/-4
SHR, f 14 0+/-5 142+/-5 99+/-2 150+/-8 103+/-5
NZH, f 179+/-3 180+/-4 97+/-2 153+/-6 101+/-10
Values are Mean +/- s.e.m. n*4 All values are statistically significant
(p<0.01).
The results suggest that the potentiation of the effect of PNS by Iso Involves 
activation of presynaptic beta 2 adrenoceptors and that this in turn may require 
activation of the renln-angiotensin system.
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Kawasaki, H.; Cline, W.H., Jnr.; Su, C.; J. Pharmacol. Exp. Ther. 23 1:23-32, 
1984 .
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